KAF2KennethFreedbergKenneth Alan Freedberg, M.D.42.36233300000000-71.0640340000000040304Freedberg, KennethAlan617/724-3341Professor of Medicinecatalyst:eCommonsLogineCommons Loginprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofvivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson10453300Marine JE, Freedberg KA, Davidoff RCardiology clinicsCost-effectiveness of stress-echocardiography. Cardiol Clin. 1999 Aug; 17(3):583-95, x.Cardiol Clin1999-08-01T00:00:001999Cost-effectiveness of stress-echocardiography.Authorship 1052871729533304Ahonkhai AA, Banigbe B, Adeola J, Bassett IV, Idigbe I, Okonkwo P, Freedberg KA, Regan S, Losina EJournal of acquired immune deficiency syndromes (1999)High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian Cohort. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):322-328.J Acquir Immune Defic Syndr2018-07-01T00:00:002018High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian Cohort.15194783Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, Le Gall S, John M, Mothe BR, Lee PK, Kalife ET, Cohen DE, Freedberg KA, Strick DA, Johnston MN, Sette A, Rosenberg ES, Mallal SA, Goulder PJ, Brander C, Walker BDJournal of virologySelection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol. 2004 Jul; 78(13):7069-78.J Virol2004-07-01T00:00:002004Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.15951459Walensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel ADMedical decision making : an international journal of the Society for Medical Decision MakingOptimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Med Decis Making. 2005 May-Jun; 25(3):321-9.Med Decis Making2005-05-01T00:00:002005Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral.Authorship 104044419561518Linas BP, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KAJournal of acquired immune deficiency syndromes (1999)Improving outcomes in state AIDS drug assistance programs. J Acquir Immune Defic Syndr. 2009 Aug 15; 51(5):513-21.J Acquir Immune Defic Syndr2009-08-15T00:00:002009Improving outcomes in state AIDS drug assistance programs.Authorship 10553468Authorship 1054798929603882Zheng A, Kumarasamy N, Huang M, Paltiel AD, Mayer KH, Rewari BB, Walensky RP, Freedberg KAJournal of the International AIDS SocietyThe cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India. J Int AIDS Soc. 2018 03; 21(3):e25085.J Int AIDS Soc2018-03-01T00:00:002018The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.29603888Luz PM, Osher B, Grinsztejn B, Maclean RL, Losina E, Stern ME, Struchiner CJ, Parker RA, Freedberg KA, Mesquita F, Walensky RP, Veloso VG, Paltiel ADJournal of the International AIDS SocietyThe cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil. J Int AIDS Soc. 2018 03; 21(3):e25096.J Int AIDS Soc2018-03-01T00:00:002018The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.Authorship 111299129566470Paltiel AD, Scharfstein JA, Seage GR, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KAMedical decision making : an international journal of the Society for Medical Decision MakingA Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making. 1998 Apr-Jun; 18(2 Suppl):S93-105.Med Decis Making1998-04-01T00:00:001998A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection.Authorship 1056088129620932Freedberg KA, Kumarasamy N, Borre ED, Ross EL, Mayer KH, Losina E, Swaminathan S, Flanigan TP, Walensky RPAIDS research and human retrovirusesClinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India. AIDS Res Hum Retroviruses. 2018 06; 34(6):486-497.AIDS Res Hum Retroviruses2018-05-03T00:00:002018Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.11192871Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MDAIDS (London, England)Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS. 2001 Jan 05; 15(1):77-85.AIDS2001-01-05T00:00:002001Understanding delay to medical care for HIV infection: the long-term non-presenter.11590529Freedberg KA, Sullivan L, Georgakis A, Savetsky J, Stone V, Samet JHHIV clinical trialsImproving participation in HIV clinical trials: impact of a brief intervention. HIV Clin Trials. 2001 May-Jun; 2(3):205-12.HIV Clin Trials2001-05-01T00:00:002001Improving participation in HIV clinical trials: impact of a brief intervention.Authorship 1107516Authorship 1058223621068674Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel ADJournal of acquired immune deficiency syndromes (1999)The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):26-35.J Acquir Immune Defic Syndr2011-01-01T00:00:002011The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.29667336Mallampati D, MacLean RL, Shapiro R, Dabis F, Engelsmann B, Freedberg KA, Leroy V, Lockman S, Walensky R, Rollins N, Ciaranello AJournal of the International AIDS SocietyOptimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk. J Int AIDS Soc. 2018 04; 21(4):e25107.J Int AIDS Soc2018-04-01T00:00:002018Optimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk.20735240Bassett IV, Wang B, Chetty S, Giddy J, Losina E, Mazibuko M, Bearnot B, Allen J, Walensky RP, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaIntensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010 Oct 01; 51(7):823-9.Clin Infect Dis2010-10-01T00:00:002010Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.21481695Lee PT, Kerry VB, Stone VE, Freedberg KA, Bangsberg DRLancet (London, England)Transforming health professionals' education. Lancet. 2011 Apr 09; 377(9773):1235; author reply 1238-9.Lancet2011-04-09T00:00:002011Transforming health professionals' education.22306583Morris BL, Scott CA, Wilkin TJ, Sax PE, Gulick RM, Freedberg KA, Schackman BRHIV clinical trialsCost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development. HIV Clin Trials. 2012 Jan-Feb; 13(1):1-10.HIV Clin Trials2012-01-01T00:00:002012Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.17828437Deuffic-Burban S, Losina E, Wang B, Gabillard D, Messou E, Divi N, Freedberg KA, Anglaret X, Yazdanpanah YEuropean journal of epidemiologyEstimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling. Eur J Epidemiol. 2007; 22(10):737-44.Eur J Epidemiol2007-09-08T00:00:002007Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.Authorship 10639671029746619Luong Nguyen LB, Yazdanpanah Y, Maman D, Wanjala S, Vandenbulcke A, Price J, Parker RA, Hennequin W, Mendiharat P, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaVoluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness. Clin Infect Dis. 2018 08 16; 67(5):719-726.Clin Infect Dis2018-08-16T00:00:002018Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.18784465Schackman BR, Scott CA, Walensky RP, Losina E, Freedberg KA, Sax PEAIDS (London, England)The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. AIDS. 2008 Oct 01; 22(15):2025-33.AIDS2008-10-01T00:00:002008The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.Authorship 1047681121209794Walensky RP, Wood R, Ciaranello AL, Paltiel AD, Lorenzana SB, Anglaret X, Stoler AW, Freedberg KAPLoS medicineScaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. PLoS Med. 2010 Dec 21; 7(12):e1000382.PLoS Med2010-12-21T00:00:002010Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis.21562129Linas BP, Wong AY, Freedberg KA, Horsburgh CRAmerican journal of respiratory and critical care medicinePriorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011 Sep 01; 184(5):590-601.Am J Respir Crit Care Med2011-09-01T00:00:002011Priorities for screening and treatment of latent tuberculosis infection in the United States.12766632Samet JH, Horton NJ, Traphagen ET, Lyon SM, Freedberg KAAlcoholism, clinical and experimental researchAlcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res. 2003 May; 27(5):862-7.Alcohol Clin Exp Res2003-05-01T00:00:002003Alcohol consumption and HIV disease progression: are they related?21599888Ciaranello AL, Park JE, Ramirez-Avila L, Freedberg KA, Walensky RP, Leroy VBMC medicineEarly infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med. 2011 May 20; 9:59.BMC Med2011-05-20T00:00:002011Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.23087386Levison JH, Wood R, Scott CA, Ciaranello AL, Martinson NA, Rusu C, Losina E, Freedberg KA, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa. Clin Infect Dis. 2013 Feb; 56(4):587-97.Clin Infect Dis2012-10-19T00:00:002012The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.16971720Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KAThe New England journal of medicineCost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med. 2006 Sep 14; 355(11):1141-53.N Engl J Med2006-09-14T00:00:002006Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.18047639Ivers LC, Freedberg KA, Mukherjee JSAIDS research and therapyProvider-initiated HIV testing in rural Haiti: low rate of missed opportunities for diagnosis of HIV in a primary care clinic. AIDS Res Ther. 2007 Nov 29; 4:28.AIDS Res Ther2007-11-29T00:00:002007Provider-initiated HIV testing in rural Haiti: low rate of missed opportunities for diagnosis of HIV in a primary care clinic.20404739Kimmel AD, Weinstein MC, Anglaret X, Goldie SJ, Losina E, Yazdanpanah Y, Messou E, Cotich KL, Walensky RP, Freedberg KAJournal of acquired immune deficiency syndromes (1999)Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):258-68.J Acquir Immune Defic Syndr2010-07-01T00:00:002010Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness.8547500Kaplan JE, Masur H, Holmes KK, Wilfert CM, Sperling R, Baker SA, Trapnell CB, Freedberg KA, Cotton D, Powderly WGClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaUSPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Clin Infect Dis. 1995 Aug; 21 Suppl 1:S12-31.Clin Infect Dis1995-08-01T00:00:001995USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group.15018702Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KAAIDS research and human retrovirusesDetecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses. 2004 Feb; 20(2):151-5.AIDS Res Hum Retroviruses2004-02-01T00:00:002004Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire.15364455Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR, Smith HE, Zhang H, Freedberg KAVaccineA therapeutic HIV vaccine: how good is good enough? Vaccine. 2004 Sep 28; 22(29-30):4044-53.Vaccine2004-09-28T00:00:002004A therapeutic HIV vaccine: how good is good enough?16482190Freedberg KAThe Journal of investigative dermatologyThe private side of the professional man. J Invest Dermatol. 2006 Mar; 126(3):533-5.J Invest Dermatol2006-03-01T00:00:002006The private side of the professional man.16705586Holmes CB, Zheng H, Martinson NA, Freedberg KA, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaOptimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost. Clin Infect Dis. 2006 Jun 15; 42(12):1772-80.Clin Infect Dis2006-05-12T00:00:002006Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost.17224538Losina E, Walensky RP, Geller A, Beddingfield FC, Wolf LL, Gilchrest BA, Freedberg KAArchives of dermatologyVisual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol. 2007 Jan; 143(1):21-8.Arch Dermatol2007-01-01T00:00:002007Visual screening for malignant melanoma: a cost-effectiveness analysis.17353721Holmes CB, Wood R, Maartens G, Freedberg KA, Losina EJournal of acquired immune deficiency syndromes (1999)Response to "CD4 cell count natural history and informative censoring in sub-Saharan Africa". J Acquir Immune Defic Syndr. 2007 Apr 01; 44(4):491.J Acquir Immune Defic Syndr2007-04-01T00:00:002007Response to "CD4 cell count natural history and informative censoring in sub-Saharan Africa".17760736Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein MC, Morand-Joubert L, Goldie SJ, Hsu HE, Walensky RP, Dalban C, Sax PE, Girard PM, Freedberg KAHIV medicineThe long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach. HIV Med. 2007 Oct; 8(7):439-50.HIV Med2007-10-01T00:00:002007The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.Authorship 107235918754802Bassett IV, Giddy J, Wang B, Lu Z, Losina E, Freedberg KA, Walensky RPHIV medicineRoutine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection. HIV Med. 2008 Nov; 9(10):863-7.HIV Med2008-08-27T00:00:002008Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection.22333751Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA, Horsburgh CR, Losina E, Freedberg KA, Walensky RPAIDS (London, England)The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS. 2012 May 15; 26(8):987-95.AIDS2012-05-15T00:00:002012The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.22558301Pho MT, Swaminathan S, Kumarasamy N, Losina E, Ponnuraja C, Uhler LM, Scott CA, Mayer KH, Freedberg KA, Walensky RPPloS oneThe cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012; 7(4):e36001.PLoS One2012-04-30T00:00:002012The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.22809695Anglaret X, Scott CA, Walensky RP, Ouattara E, Losina E, Moh R, Becker JE, Uhler L, Danel C, Messou E, Eholié S, Freedberg KAAntiviral therapyCould early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis. Antivir Ther. 2013; 18(1):45-55.Antivir Ther2012-07-18T00:00:002012Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.22912845Hom JK, Wang B, Chetty S, Giddy J, Mazibuko M, Allen J, Walensky RP, Losina E, Freedberg KA, Bassett IVPloS oneDrug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa. PLoS One. 2012; 7(8):e43281.PLoS One2012-08-17T00:00:002012Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.2028-07-31FREEDBERG, KENNETH ALAN2004-07-01Optimizing HIV Care in Less Developed CountriesR37AI058736Principal Investigator8279595Glotzer DE, Bauchner H, Freedberg KA, Palfrey SAmerican journal of public healthScreening for childhood lead poisoning: a cost-minimization analysis. Am J Public Health. 1994 Jan; 84(1):110-2.Am J Public Health1994-01-01T00:00:001994Screening for childhood lead poisoning: a cost-minimization analysis.19620143Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina EAnnals of internal medicineWhen to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009 Aug 04; 151(3):157-66.Ann Intern Med2009-07-20T00:00:002009When to start antiretroviral therapy in resource-limited settings.20023438Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, Ross D, Katz JN, Walensky RP, Freedberg KA, Losina EAIDS (London, England)Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS. 2010 Jan; 24 Suppl 1:S37-44.AIDS2010-01-01T00:00:002010Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.20539078Loubiere S, Meiners C, Sloan C, Freedberg KA, Yazdanpanah YCurrent opinion in HIV and AIDSEconomic evaluation of ART in resource-limited countries. Curr Opin HIV AIDS. 2010 May; 5(3):225-31.Curr Opin HIV AIDS2010-05-01T00:00:002010Economic evaluation of ART in resource-limited countries.20976112Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, Pillonel J, Poullié AI, Scemama O, Deuffic-Burban S, Losina E, Walensky RP, Freedberg KA, Paltiel ADPloS oneRoutine HIV screening in France: clinical impact and cost-effectiveness. PLoS One. 2010 Oct 01; 5(10):e13132.PLoS One2010-10-01T00:00:002010Routine HIV screening in France: clinical impact and cost-effectiveness.22027877Bassett IV, Chetty S, Wang B, Mazibuko M, Giddy J, Lu Z, Walensky RP, Freedberg KA, Losina EJournal of acquired immune deficiency syndromes (1999)Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa. J Acquir Immune Defic Syndr. 2012 Jan 01; 59(1):25-30.J Acquir Immune Defic Syndr2012-01-01T00:00:002012Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.22491339Linas BP, Wong AY, Schackman BR, Kim AY, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men. Clin Infect Dis. 2012 Jul; 55(2):279-90.Clin Infect Dis2012-04-04T00:00:002012Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.23383147Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN, Coleman SM, Bogart LM, Freedberg KA, Walensky RP, Bassett IVPloS oneRisk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS One. 2013; 8(1):e55305.PLoS One2013-01-28T00:00:002013Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa.Authorship 1091437630182030Neilan AM, Cohn JE, Lemaire JF, Sacks E, Alban R, Freedberg KA, Walensky RP, Ciaranello ALOpen forum infectious diseasesHIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing? Open Forum Infect Dis. 2018 Aug; 5(8):ofy170.Open Forum Infect Dis2018-08-29T00:00:002018HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?20516555Yazdanpanah Y, Wolf LL, Anglaret X, Gabillard D, Walensky RP, Moh R, Danel C, Sloan CE, Losina E, Freedberg KAAntiviral therapyCD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials. Antivir Ther. 2010; 15(3):351-61.Antivir Ther2010-01-01T00:00:002010CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.22398569Ouattara EN, Anglaret X, Wong AY, Chu J, Hsu HE, Danel C, Eholié S, Moh R, Gabillard D, Walensky RP, Freedberg KAAIDS (London, England)Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age. AIDS. 2012 Mar 13; 26(5):625-34.AIDS2012-03-13T00:00:002012Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.18350223Ojikutu BO, Zheng H, Walensky RP, Lu Z, Losina E, Giddy J, Freedberg KASouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskundePredictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J. 2008 Mar; 98(3):204-8.S Afr Med J2008-03-01T00:00:002008Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.22427925Ahonkhai AA, Noubary F, Munro A, Stark R, Wilke M, Freedberg KA, Wood R, Losina EPloS oneNot all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program. PLoS One. 2012; 7(3):e32993.PLoS One2012-03-12T00:00:002012Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program.Center for Public Leadership Fellows17133193Freedberg KA, Hirschhorn LR, Schackman BR, Wolf LL, Martin LA, Weinstein MC, Goldin S, Paltiel AD, Katz C, Goldie SJ, Losina EJournal of acquired immune deficiency syndromes (1999)Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients. J Acquir Immune Defic Syndr. 2006 Dec 01; 43 Suppl 1:S113-8.J Acquir Immune Defic Syndr2006-12-01T00:00:002006Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients.17288069Schackman BR, Freedberg KA, Goldie SJ, Weinstein MC, Swartz KHealth care financing reviewBudget impact of Medicaid Section 1115 demonstrations for early HIV treatment. Health Care Financ Rev. 2005; 26(4):67-80.Health Care Financ Rev2005-01-01T00:00:002005Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment.17620747Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RPAIDS (London, England)Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS. 2007 Jul; 21 Suppl 4:S117-28.AIDS2007-07-01T00:00:002007Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.7898292Glotzer DE, Freedberg KA, Bauchner HMedical decision making : an international journal of the Society for Medical Decision MakingManagement of childhood lead poisoning: clinical impact and cost-effectiveness. Med Decis Making. 1995 Jan-Mar; 15(1):13-24.Med Decis Making1995-01-01T00:00:001995Management of childhood lead poisoning: clinical impact and cost-effectiveness.18608072Jean-Jacques M, Walensky RP, Aaronson WH, Chang Y, Freedberg KAAIDS careLate diagnosis of HIV infection at two academic medical centers: 1994-2004. AIDS Care. 2008 Sep; 20(8):977-83.AIDS Care2008-09-01T00:00:002008Late diagnosis of HIV infection at two academic medical centers: 1994-2004.19582895April MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, Losina E, Paltiel AD, Wood RJournal of acquired immune deficiency syndromes (1999)HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies. J Acquir Immune Defic Syndr. 2009 Jul 01; 51(3):310-6.J Acquir Immune Defic Syndr2009-07-01T00:00:002009HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies.Authorship 1108913530355418Kubiak RW, Herbeck JT, Coleman SM, Ross D, Freedberg K, Bassett IV, Drain PKThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung DiseaseUrinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients. Int J Tuberc Lung Dis. 2018 11 01; 22(11):1366-1373.Int J Tuberc Lung Dis2018-11-01T00:00:002018Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients.22180526Haas DW, Kuritzkes DR, Ritchie MD, Amur S, Gage BF, Maartens G, Masys D, Fellay J, Phillips E, Ribaudo HJ, Freedberg KA, Petropoulos C, Manolio TA, Gulick RM, Haubrich R, Kim P, Dehlinger M, Abebe R, Telenti AHIV clinical trialsPharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clin Trials. 2011 Sep-Oct; 12(5):277-85.HIV Clin Trials2011-09-01T00:00:002011Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases.22427821Levison JH, Orrell C, Gallien S, Kuritzkes DR, Fu N, Losina E, Freedberg KA, Wood RPloS oneVirologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa. PLoS One. 2012; 7(3):e32144.PLoS One2012-03-13T00:00:002012Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa.Authorship 1334927Authorship 13372677618986Samet JH, Libman H, LaBelle C, Steger K, Lewis R, Craven DE, Freedberg KAArchives of internal medicineA model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med. 1995 Aug 7-21; 155(15):1629-33.Arch Intern Med1995-08-01T00:00:001995A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus.7880186Bergquist SR, Felson DT, Prashker MJ, Freedberg KAArthritis and rheumatismThe cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1995 Mar; 38(3):326-33.Arthritis Rheum1995-03-01T00:00:001995The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate.7999177Orlander JD, Samet JH, Kazis L, Freedberg KA, Libman HAcademic medicine : journal of the Association of American Medical CollegesImproving medical residents' attitudes toward HIV-infected persons through training in an HIV staging and triage clinic. Acad Med. 1994 Dec; 69(12):1001-3.Acad Med1994-12-01T00:00:001994Improving medical residents' attitudes toward HIV-infected persons through training in an HIV staging and triage clinic.Authorship 10677614221051598Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, Olender SA, Ostrowski M, Owen WF, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao MScience (New York, N.Y.)The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7.Science2010-11-04T00:00:002010The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.21857284Messou E, Kouakou M, Gabillard D, Gouessé P, Koné M, Tchehy A, Losina E, Freedberg KA, Dri-Yoman TN, Anzian A, Toure S, Anglaret XJournal of acquired immune deficiency syndromes (1999)Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'Ivoire. J Acquir Immune Defic Syndr. 2011 Jul 01; 57 Suppl 1:S34-9.J Acquir Immune Defic Syndr2011-07-01T00:00:002011Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'Ivoire.21990259Losina E, Freedberg KABMJ (Clinical research ed.)Life expectancy in HIV. BMJ. 2011 Oct 11; 343:d6015.BMJ2011-10-11T00:00:002011Life expectancy in HIV.22173233Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler CClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire. Clin Infect Dis. 2012 Mar 01; 54(5):714-23.Clin Infect Dis2012-02-04T00:00:002012AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.7859142Lebow JM, O'Connell JJ, Oddleifson S, Gallagher KM, Seage GR, Freedberg KAJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology AssociationAIDS among the homeless of Boston: a cohort study. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 01; 8(3):292-6.J Acquir Immune Defic Syndr Hum Retrovirol1995-03-01T00:00:001995AIDS among the homeless of Boston: a cohort study.7942936Samet JH, Retondo MJ, Freedberg KA, Stein MD, Heeren T, Libman HThe American journal of medicineFactors associated with initiation of primary medical care for HIV-infected persons. Am J Med. 1994 Oct; 97(4):347-53.Am J Med1994-10-01T00:00:001994Factors associated with initiation of primary medical care for HIV-infected persons.10340370Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JMJAMAThe clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999 May 19; 281(19):1822-9.JAMA1999-05-19T00:00:001999The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.10520668Yazdanpanah Y, Goldie SJ, Salamon R, Mouton Y, Freedberg KALancet (London, England)Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1? Lancet. 1999 Oct 09; 354(9186):1305-6.Lancet1999-10-09T00:00:001999Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?11248160Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJThe New England journal of medicineThe cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001 Mar 15; 344(11):824-31.N Engl J Med2001-03-15T00:00:002001The cost effectiveness of combination antiretroviral therapy for HIV disease.12456226Kuehne FC, Bethe U, Freedberg K, Goldie SJArchives of internal medicineTreatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness. Arch Intern Med. 2002 Dec 9-23; 162(22):2545-56.Arch Intern Med2002-12-01T00:00:002002Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness.Authorship 111550317667332Bassett IV, Giddy J, Nkera J, Wang B, Losina E, Lu Z, Freedberg KA, Walensky RPJournal of acquired immune deficiency syndromes (1999)Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr. 2007 Oct 01; 46(2):181-6.J Acquir Immune Defic Syndr2007-10-01T00:00:002007Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department.Authorship 1126900530611192Bajema KL, Bassett IV, Coleman SM, Ross D, Freedberg KA, Wald A, Drain PKBMC infectious diseasesSubclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort. BMC Infect Dis. 2019 Jan 05; 19(1):14.BMC Infect Dis2019-01-05T00:00:002019Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort.Authorship 11272641530683239Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, Lawn SD, Walensky RPThe Lancet. Global healthCost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. Lancet Glob Health. 2019 02; 7(2):e200-e208.Lancet Glob Health2019-02-01T00:00:002019Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.22474224Walensky RP, Park JE, Wood R, Freedberg KA, Scott CA, Bekker LG, Losina E, Mayer KH, Seage GR, Paltiel ADClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis. 2012 May; 54(10):1504-13.Clin Infect Dis2012-04-03T00:00:002012The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women.Authorship 1129115830707224Chen Q, Larochelle MR, Weaver DT, Lietz AP, Mueller PP, Mercaldo S, Wakeman SE, Freedberg KA, Raphel TJ, Knudsen AB, Pandharipande PV, Chhatwal JJAMA network openPrevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States. JAMA Netw Open. 2019 02 01; 2(2):e187621.JAMA Netw Open2019-02-01T00:00:002019Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States.Authorship 10799948717596Freedberg KA, Hardy WD, Holzman RS, Tosteson AN, Craven DEMedical decision making : an international journal of the Society for Medical Decision MakingValidating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients. Med Decis Making. 1996 Jan-Mar; 16(1):29-35.Med Decis Making1996-01-01T00:00:001996Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.Authorship 1094402Authorship 1132246930737187Frank SC, Cohn J, Dunning L, Sacks E, Walensky RP, Mukherjee S, Dugdale CM, Turunga E, Freedberg KA, Ciaranello ALThe lancet. HIVClinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. Lancet HIV. 2019 03; 6(3):e182-e190.Lancet HIV2019-02-05T00:00:002019Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study.Authorship 1131055Authorship 1270984Authorship 11381065Authorship 1136790730865169Schackman BR, Jeng PJ, Flash MJE, Mejia M, Oksuzyan S, Scott JA, Freedberg KA, Kulkarni SP, Garland WHJournal of acquired immune deficiency syndromes (1999)Cost of an HIV Medical Care Coordination Program in Los Angeles County. J Acquir Immune Defic Syndr. 2019 05 01; 81(1):e15-e17.J Acquir Immune Defic Syndr2019-05-01T00:00:002019Cost of an HIV Medical Care Coordination Program in Los Angeles County.30869008Abuelezam NN, McCormick AW, Surface ED, Fussell T, Freedberg KA, Lipsitch M, Seage GREpidemiology and infectionModelling the epidemiologic impact of achieving UNAIDS fast-track 90-90-90 and 95-95-95 targets in South Africa. Epidemiol Infect. 2019 01; 147:e122.Epidemiol Infect2019-01-01T00:00:002019Modelling the epidemiologic impact of achieving UNAIDS fast-track 90-90-90 and 95-95-95 targets in South Africa.D044966Chemicals & Drugs43917340.47925Anti-Retroviral AgentsD003362Activities & BehaviorsConcepts & Ideas168154620.388922Cost-Benefit AnalysisAuthorship 11426128Authorship 11472379Authorship 11471851830990464Neilan AM, Patel K, Agwu AL, Bassett IV, Amico KR, Crespi CM, Gaur AH, Horvath KJ, Powers KA, Rendina HJ, Hightow-Weidman LB, Li X, Naar S, Nachman S, Parsons JT, Simpson KN, Stanton BF, Freedberg KA, Bangs AC, Hudgens MG, Ciaranello ALJMIR research protocolsModel-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161). JMIR Res Protoc. 2019 Apr 16; 8(4):e9898.JMIR Res Protoc2019-04-16T00:00:002019Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161).30934067Dugdale CM, Ciaranello AL, Bekker LG, Stern ME, Myer L, Wood R, Sax PE, Abrams EJ, Freedberg KA, Walensky RPAnnals of internal medicineRisks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study. Ann Intern Med. 2019 05 07; 170(9):614-625.Ann Intern Med2019-04-02T00:00:002019Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.30921454Kazemian P, Costantini S, Kumarasamy N, Paltiel AD, Mayer KH, Chandhiok N, Walensky RP, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India. Clin Infect Dis. 2020 02 03; 70(4):633-642.Clin Infect Dis2020-02-03T00:00:002020The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.D015658Disorders1931167640.15209HIV InfectionsD019380Chemicals & Drugs64943200.317603Anti-HIV AgentsD017088Disorders2796640.735919AIDS-Related Opportunistic InfectionsAuthorship 1152016731055599Hyle EP, Scott JA, Sax PE, Millham LRI, Dugdale CM, Weinstein MC, Freedberg KA, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaClinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States. Clin Infect Dis. 2020 03 17; 70(7):1353-1363.Clin Infect Dis2020-03-17T00:00:002020Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States.Health Policy and ManagementMedicineOrthopedic SurgerySurgeryGeneral Internal MedicineInfectious DiseaseOncologyBeth Israel Deaconess Medical CenterBrigham and Women's HospitalDana-Farber Cancer InstituteHarvard T.H. Chan School of Public HealthJohn F. Kennedy School of GovernmentMassachusetts General HospitalWWF1WafaieFawziWafaie W. Fawzi42.33546850000000-71.1015102000000075957Fawzi, WafaieRichard Saltonstall Professor of Population Sciences, and Professor of Nutrition, Epidemiology, and Global HealthKHM2KennethMayerKenneth Hugh Mayer, M.D.42.34652700000000-71.0878720000000068578Mayer, KennethProfessor of MedicineAuthorship 1152229731085063Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BPThe International journal on drug policyCost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. Int J Drug Policy. 2019 10; 72:160-168.Int J Drug Policy2019-05-10T00:00:002019Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.ALC11AndreaCiaranello MD MPHAndrea Ciaranello MD MPH, M.D.42.36233300000000-71.0640340000000066425Ciaranello MD MPH, AndreaAssociate Professor of MedicinePES2PaulSaxPaul Edward Sax, M.D.42.33510370000000-71.1061649000000067048Sax, PaulProfessor of MedicineAuthorship 1156892731131623James AJ, Marable D, Cubbison CV, Tarbox AA, Mejia DL, Oo SA, Freedberg KA, Levison JHAIDS careHIV testing in a large community health center serving a multi-cultural patient population: A qualitative study of providers. AIDS Care. 2019 12; 31(12):1585-1592.AIDS Care2019-05-27T00:00:002019HIV testing in a large community health center serving a multi-cultural patient population: A qualitative study of providers.KEL13KerryKilbridgeKerry E. Laing Kilbridge, M.D.42.36233300000000-71.0640340000000076085Kilbridge, KerryAssistant Professor of MedicineAEV6AngeloVolandesAngelo Volandes, M.D.42.36233300000000-71.0640340000000081881Volandes, AngeloAssociate Professor of MedicineIVB1IngridBassettIngrid Valerie Bassett, M.D.42.36241700000000-71.0689370000000072524Bassett, IngridProfessor of MedicineEPH10EmilyHyleEmily Parker Hyle, M.D.42.36241700000000-71.0689370000000076701Hyle, EmilyAssociate Professor of MedicineRochelleWalenskyRochelle P. Walensky, M.D.42.36233300000000-71.0640340000000015654Walensky, RochelleFellow, Dept/Prog (Stip)JH198JessicaHabererJessica Haberer, M.D.42.37283520000000-71.1212038000000077031Haberer, JessicaProfessor of MedicineEL79ElenaLosinaElena Losina, Ph.D.42.33510370000000-71.1061649000000081127Losina, ElenaRobert W. Lovett Professor of Orthopedic Surgery11358selected publications8.833760.00163178673research areas16.56860.00819131116coauthor of837.7450.391760similar toAuthorship 1164060631191914Murray BR, Kratka A, Scherr KA, Eyal N, Blumenthal-Barby J, Freedberg KA, Kuritzkes DR, Hammitt JK, Edifor R, Katz MN, Pollak KI, Zikmund-Fisher BJ, Halpern SD, Barks MC, Ubel PAJournal of virus eradicationWhat risk of death would people take to be cured of HIV and why? A survey of people living with HIV. J Virus Erad. 2019 Apr 01; 5(2):109-115.J Virus Erad2019-04-01T00:00:002019What risk of death would people take to be cured of HIV and why? A survey of people living with HIV.JSW2JoelWeissmanJoel Steven Weissman, Ph.D.42.36233300000000-71.0640340000000062712Weissman, JoelProfessor of SurgeryDB1DavidBlumenthalDavid Blumenthal, M.D.42.36233300000000-71.0640340000000056469Blumenthal, DavidProfessor of the Practice of Public Health and Health PolicyAuthorship 1290721Authorship 1165255731243898Bassett IV, Huang M, Cloete C, Candy S, Giddy J, Frank SC, Freedberg KA, Losina E, Walensky RP, Parker RAJournal of the International AIDS SocietyUsing national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa. J Int AIDS Soc. 2019 06; 22(6):e25326.J Int AIDS Soc2019-06-01T00:00:002019Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa.Authorship 11671378Authorship 11672271231265470Lee DJ, Kumarasamy N, Resch SC, Sivaramakrishnan GN, Mayer KH, Tripathy S, Paltiel AD, Freedberg KA, Reddy KPPloS oneRapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector. PLoS One. 2019; 14(7):e0218890.PLoS One2019-07-02T00:00:002019Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.31247009Ouattara EN, MacLean RL, Danel C, Borre ED, Gabillard D, Huang M, Moh R, Paltiel AD, Eholié SP, Walensky RP, Anglaret X, Freedberg KAPloS oneCost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis. PLoS One. 2019; 14(6):e0219068.PLoS One2019-06-27T00:00:002019Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.Authorship 11758131131334298Desmonde S, Frank SC, Coovadia A, Dahourou DL, Hou T, Abrams EJ, Amorissani-Folquet M, Walensky RP, Strehlau R, Penazzato M, Freedberg KA, Kuhn L, Leroy V, Ciaranello ALOpen forum infectious diseasesCost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Jul; 6(7):ofz276.Open Forum Infect Dis2019-06-11T00:00:002019Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.Authorship 1323817Authorship 1464024Authorship 1399527Authorship 1192648931553735Banigbe B, Audet CM, Okonkwo P, Arije OO, Bassi E, Clouse K, Simmons M, Aliyu MH, Freedberg KA, Ahonkhai AAPloS oneEffect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria. PLoS One. 2019; 14(9):e0221809.PLoS One2019-09-25T00:00:002019Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria.Authorship 110797331689133Reddy KP, Horsburgh CR, Wood R, Fields NF, Girouard MP, Costantini S, Hou T, Freedberg KA, Walensky RPAnnals of the American Thoracic SocietyShortened Tuberculosis Treatment for People with HIV in South Africa. A Model-based Evaluation and Cost-effectiveness Analysis. Ann Am Thorac Soc. 2020 02; 17(2):202-211.Ann Am Thorac Soc2020-02-01T00:00:002020Shortened Tuberculosis Treatment for People with HIV in South Africa. A Model-based Evaluation and Cost-effectiveness Analysis.Authorship 12031348Authorship 1204705631730630Dugdale CM, Phillips TK, Myer L, Hyle EP, Brittain K, Freedberg KA, Cunnama L, Walensky RP, Zerbe A, Weinstein MC, Abrams EJ, Ciaranello ALPloS oneCost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa. PLoS One. 2019; 14(11):e0225104.PLoS One2019-11-15T00:00:002019Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa.true1Assistant Professor of MedicineAssistant Professor of Medicinetrue1Robert W. Lovett Professor of Orthopedic SurgeryRobert W. Lovett Professor of Orthopedic Surgerytrue1Associate Professor of MedicineAssociate Professor of Medicinetrue1Associate Professor of MedicineAssociate Professor of MedicineAuthorship 1458336Authorship 1475465Authorship 1214641731900813Fridman I, Ubel PA, Blumenthal-Barby J, England CV, Currier JS, Eyal N, Freedberg KA, Halpern SD, Kelley CF, Kuritzkes DR, Le CN, Lennox JL, Pollak KI, Zikmund-Fisher BJ, Scherr KAAIDS and behavior"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication. AIDS Behav. 2020 Jul; 24(7):2054-2061.AIDS Behav2020-07-01T00:00:002020"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.31929403Millham LRI, Scott JA, Sax PE, Shebl FM, Reddy KP, Losina E, Walensky RP, Freedberg KAJournal of acquired immune deficiency syndromes (1999)Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States. J Acquir Immune Defic Syndr. 2020 02 01; 83(2):148-156.J Acquir Immune Defic Syndr2020-02-01T00:00:002020Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States.Authorship 12165881031909083Flash MJE, Garland WH, Martey EB, Schackman BR, Oksuzyan S, Scott JA, Jeng PJ, Rubio M, Losina E, Freedberg KA, Kulkarni SP, Hyle EPOpen forum infectious diseasesCost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles County. Open Forum Infect Dis. 2019 Dec; 6(12):ofz537.Open Forum Infect Dis2019-12-16T00:00:002019Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles County.Authorship 12185918Authorship 1220242431975656Murray EJ, Robins JM, Seage GR, Freedberg KA, Hernán MAMedical decision making : an international journal of the Society for Medical Decision MakingThe Challenges of Parameterizing Direct Effects in Individual-Level Simulation Models. Med Decis Making. 2020 01; 40(1):106-111.Med Decis Making2020-01-01T00:00:002020The Challenges of Parameterizing Direct Effects in Individual-Level Simulation Models.Authorship 16859713Authorship 1210661Authorship 12090210Authorship 1231761432150602Walensky RP, Horn T, McCann NC, Freedberg KA, Paltiel ADAnnals of internal medicineComparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis. Ann Intern Med. 2020 05 05; 172(9):583-590.Ann Intern Med2020-03-10T00:00:002020Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.Authorship 169844832404384Reddy KP, Bulteel AJB, Levy DE, Torola P, Hyle EP, Hou T, Osher B, Yu L, Shebl FM, Paltiel AD, Freedberg KA, Weinstein MC, Rigotti NA, Walensky RPBMJ openNovel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population. BMJ Open. 2020 05 12; 10(5):e032579.BMJ Open2020-05-12T00:00:002020Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population.Authorship 124997511Authorship 1253375232501664Weinstein MC, Freedberg KA, Hyle EP, Paltiel ADThe New England journal of medicineWaiting for Certainty on Covid-19 Antibody Tests - At What Cost? N Engl J Med. 2020 Aug 06; 383(6):e37.N Engl J Med2020-06-05T00:00:002020Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?Authorship 12564497Authorship 12549131332526280Kazemian P, Costantini S, Neilan AM, Resch SC, Walensky RP, Weinstein MC, Freedberg KAJournal of biomedical informaticsA novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease. J Biomed Inform. 2020 07; 107:103475.J Biomed Inform2020-06-08T00:00:002020A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease.32520910McCann NC, Cohn J, Flanagan C, Sacks E, Mukherjee S, Walensky RP, Adetunji O, Maeka KK, Panella C, Chadambuka A, Mafaune H, Odhiambo C, Freedberg KA, Ciaranello ALJournal of acquired immune deficiency syndromes (1999)Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis. J Acquir Immune Defic Syndr. 2020 07 01; 84 Suppl 1:S12-S21.J Acquir Immune Defic Syndr2020-07-01T00:00:002020Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.Authorship 12581191332587893Soeteman DI, Resch SC, Jalal H, Dugdale CM, Penazzato M, Weinstein MC, Phillips A, Hou T, Abrams EJ, Dunning L, Newell ML, Pei PP, Freedberg KA, Walensky RP, Ciaranello ALMDM policy & practiceDeveloping and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers. MDM Policy Pract. 2020 Jan-Jun; 5(1):2381468320932894.MDM Policy Pract2020-06-12T00:00:002020Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers.Authorship 12656121732637979Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, Fitzmaurice KP, Flanagan C, Hyle EP, Neilan AM, Mohareb AM, Bekker LG, Lessells RJ, Ciaranello AL, Wood R, Losina E, Freedberg KA, Kazemian P, Siedner MJmedRxiv : the preprint server for health sciencesCost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. medRxiv. 2020 Oct 11.medRxiv2020-10-11T00:00:002020Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.Authorship 1552714Authorship 1456713Authorship 1600439Authorship 1271454532730625Neilan AM, Bulteel AJB, Hosek SG, Foote JHA, Freedberg KA, Landovitz RJ, Walensky RP, Resch SC, Kazemian P, Paltiel AD, Weinstein MC, Wilson CM, Ciaranello ALClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2021 10 05; 73(7):e1927-e1935.Clin Infect Dis2021-10-05T00:00:002021Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States.Authorship 12736571432743604Neilan AM, Losina E, Bangs AC, Flanagan C, Panella C, Eskibozkurt GE, Mohareb A, Hyle EP, Scott JA, Weinstein MC, Siedner MJ, Reddy KP, Harling G, Freedberg KA, Shebl FM, Kazemian P, Ciaranello ALmedRxiv : the preprint server for health sciencesClinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts. medRxiv. 2020 Jul 24.medRxiv2020-07-24T00:00:002020Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts.Authorship 12780061832817967Baggett TP, Scott JA, Le MH, Shebl FM, Panella C, Losina E, Flanagan C, Gaeta JM, Neilan A, Hyle EP, Mohareb A, Reddy KP, Siedner MJ, Harling G, Weinstein MC, Ciaranello A, Kazemian P, Freedberg KAmedRxiv : the preprint server for health sciencesClinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic. medRxiv. 2020 Oct 20.medRxiv2020-10-20T00:00:002020Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic.Authorship 12866154Authorship 128416010Authorship 12845081432908989Losina E, Leifer V, Millham L, Panella C, Hyle EP, Mohareb AM, Neilan AM, Ciaranello AL, Kazemian P, Freedberg KAmedRxiv : the preprint server for health sciencesCollege campuses and COVID-19 mitigation: clinical and economic value. medRxiv. 2020 Sep 05.medRxiv2020-09-05T00:00:002020College campuses and COVID-19 mitigation: clinical and economic value.32926822Walensky RP, Horn T, McCann NC, Freedberg KA, Paltiel ADAnnals of internal medicineComparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis. Ann Intern Med. 2020 09 15; 173(6):507-508.Ann Intern Med2020-09-15T00:00:002020Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis.32945845Neilan AM, Losina E, Bangs AC, Flanagan C, Panella C, Eskibozkurt GE, Mohareb A, Hyle EP, Scott JA, Weinstein MC, Siedner MJ, Reddy KP, Harling G, Freedberg KA, Shebl FM, Kazemian P, Ciaranello ALClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaClinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts. Clin Infect Dis. 2021 11 02; 73(9):e2908-e2917.Clin Infect Dis2021-11-02T00:00:002021Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts.Global Health and PopulationAuthorship 12930921133031440Ahonkhai AA, Regan S, Idigbe I, Adeniyi O, Aliyu MH, Okonkwo P, Adeola J, Losina E, Musa Z, Ezechi O, Freedberg KAPloS oneThe impact of user fees on uptake of HIV services and adherence to HIV treatment: Findings from a large HIV program in Nigeria. PLoS One. 2020; 15(10):e0238720.PLoS One2020-10-08T00:00:002020The impact of user fees on uptake of HIV services and adherence to HIV treatment: Findings from a large HIV program in Nigeria.Authorship 1299469233106850Luong Nguyen LB, Freedberg KA, Wanjala S, Maman D, Szumilin E, Mendiharat P, Yazdanpanah YThe Journal of infectious diseasesComparative Effectiveness of Interventions to Improve the HIV Continuum of Care and HIV Preexposure Prophylaxis in Kenya: A Model-Based Analysis. J Infect Dis. 2022 03 15; 225(6):1032-1039.J Infect Dis2022-03-15T00:00:002022Comparative Effectiveness of Interventions to Improve the HIV Continuum of Care and HIV Preexposure Prophylaxis in Kenya: A Model-Based Analysis.33188729Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, Fitzmaurice KP, Flanagan C, Hyle EP, Neilan AM, Mohareb AM, Bekker LG, Lessells RJ, Ciaranello AL, Wood R, Losina E, Freedberg KA, Kazemian P, Siedner MJThe Lancet. Global healthCost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021 02; 9(2):e120-e129.Lancet Glob Health2020-11-11T00:00:002020Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.33200169Reddy KP, Denkinger CM, Broger T, McCann NC, Gupta-Wright A, Kerkhoff AD, Pei PP, Shebl FM, Fielding KL, Nicol MP, Horsburgh CR, Meintjes G, Freedberg KA, Wood R, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus. Clin Infect Dis. 2021 10 05; 73(7):e2077-e2085.Clin Infect Dis2021-10-05T00:00:002021Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus.Authorship 130252213Authorship 13061781733347322Losina E, Leifer V, Millham L, Panella C, Hyle EP, Mohareb AM, Neilan AM, Ciaranello AL, Kazemian P, Freedberg KAAnnals of internal medicineCollege Campuses and COVID-19 Mitigation: Clinical and Economic Value. Ann Intern Med. 2021 04; 174(4):472-483.Ann Intern Med2020-12-21T00:00:002020College Campuses and COVID-19 Mitigation: Clinical and Economic Value.33351082Baggett TP, Scott JA, Le MH, Shebl FM, Panella C, Losina E, Flanagan C, Gaeta JM, Neilan A, Hyle EP, Mohareb A, Reddy KP, Siedner MJ, Harling G, Weinstein MC, Ciaranello A, Kazemian P, Freedberg KAJAMA network openClinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic. JAMA Netw Open. 2020 12 01; 3(12):e2028195.JAMA Netw Open2020-12-01T00:00:002020Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic.Authorship 131027710Authorship 131205318Authorship 13211221833474817Dunning L, Gandhi AR, Penazzato M, Soeteman DI, Revill P, Frank S, Phillips A, Dugdale C, Abrams E, Weinstein MC, Newell ML, Collins IJ, Doherty M, Vojnov L, Fassinou Ekouévi P, Myer L, Mushavi A, Freedberg KA, Ciaranello ALJournal of the International AIDS SocietyOptimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis. J Int AIDS Soc. 2021 01; 24(1):e25651.J Int AIDS Soc2021-01-01T00:00:002021Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis.Authorship 13260881633547993Neilan AM, Bangs AC, Hudgens M, Patel K, Agwu AL, Bassett IV, Gaur AH, Hyle EP, Crespi CM, Horvath KJ, Dugdale CM, Powers KA, Rendina HJ, Weinstein MC, Walensky RP, Freedberg KA, Ciaranello ALAIDS and behaviorModeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections. AIDS Behav. 2021 Sep; 25(9):2973-2984.AIDS Behav2021-02-06T00:00:002021Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections.Authorship 1525922Authorship 1702118Authorship 1354652834013291Reddy KP, Fitzmaurice KP, Scott JA, Harling G, Lessells RJ, Panella C, Shebl FM, Freedberg KA, Siedner MJmedRxiv : the preprint server for health sciencesClinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa. medRxiv. 2021 Nov 13.medRxiv2021-11-13T00:00:002021Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa.Authorship 1372013834189169Neilan AM, Cohn J, Sacks E, Gandhi AR, Fassinou P, Walensky RP, Kouadio MN, Freedberg KA, Ciaranello ALOpen forum infectious diseasesEvaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d'Ivoire Modeling Analysis. Open Forum Infect Dis. 2021 Jun; 8(6):ofab225.Open Forum Infect Dis2021-05-13T00:00:002021Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d'Ivoire Modeling Analysis.true1Professor of MedicineProfessor of MedicineAuthorship 188568Authorship 1406839834716349Reddy KP, Fitzmaurice KP, Scott JA, Harling G, Lessells RJ, Panella C, Shebl FM, Freedberg KA, Siedner MJNature communicationsClinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa. Nat Commun. 2021 10 29; 12(1):6238.Nat Commun2021-10-29T00:00:002021Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa.35028333Stanic T, McCann N, Penazzato M, Flanagan C, Essajee S, Freedberg KA, Doherty M, Putta N, Myer L, Siberry GK, Collins IJ, Vojnov L, Abrams E, Soeteman DI, Ciaranello ALOpen forum infectious diseasesCost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa. Open Forum Infect Dis. 2022 Jan; 9(1):ofab603.Open Forum Infect Dis2021-12-05T00:00:002021Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa.35048515Flanagan CF, McCann N, Stover J, Freedberg KA, Ciaranello ALJournal of the International AIDS SocietyDo not forget the children: a model-based analysis on the potential impact of COVID-19-associated interruptions in paediatric HIV prevention and care. J Int AIDS Soc. 2022 01; 25(1):e25864.J Int AIDS Soc2022-01-01T00:00:002022Do not forget the children: a model-based analysis on the potential impact of COVID-19-associated interruptions in paediatric HIV prevention and care.Authorship 14269806Authorship 14257694Authorship 2076788Authorship 2016727Authorship 216754Authorship 2151302Authorship 2388381Authorship 1430954535099992Neilan AM, Landovitz RJ, Le MH, Grinsztejn B, Freedberg KA, McCauley M, Wattananimitgul N, Cohen MS, Ciaranello AL, Clement ME, Reddy KP, Hyle EP, Paltiel AD, Walensky RPAnnals of internal medicineCost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis. Ann Intern Med. 2022 04; 175(4):479-489.Ann Intern Med2022-02-01T00:00:002022Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.Authorship 1438702935226343Pierce LJ, Regan S, Idigbe I, Adeola J, Musa Z, Ezechi O, Oladeji B, Gureje O, Freedberg KA, Okonkwo P, Ahonkhai AAInternational journal of behavioral medicinePsychological Distress Increases 30-Fold Among People with HIV in the First Year on ART in Nigeria-a Call for Integrated Mental Health Services. Int J Behav Med. 2022 Feb 28.Int J Behav Med2022-02-28T00:00:002022Psychological Distress Increases 30-Fold Among People with HIV in the First Year on ART in Nigeria-a Call for Integrated Mental Health Services.Authorship 144470119Authorship 14473216Authorship 14469892035511194Mohareb AM, Liu AF, Kim AY, Coffie PA, Kouamé MG, Freedberg KA, Boyd A, Hyle EPThe Journal of infectious diseasesClearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis. J Infect Dis. 2022 11 11; 226(10):1761-1770.J Infect Dis2022-11-11T00:00:002022Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis.35471644Kazemian P, Ding DD, Scott JA, Feser MK, Biello K, Thomas BE, Dange A, Bedoya CA, Balu V, Rawat S, Kumarasamy N, Mimiaga MJ, O'Cleirigh C, Weinstein MC, Kumar JP, Kumar S, Mayer KH, Safren SA, Freedberg KAAIDS (London, England)The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India. AIDS. 2022 07 15; 36(9):1223-1232.AIDS2022-04-26T00:00:002022The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India.35420554Resch SC, Foote JHA, Wirth KE, Lasry A, Scott JA, Moore J, Shebl FM, Gaolathe T, Feser MK, Lebelonyane R, Hyle EP, Mmalane MO, Bachanas P, Yu L, Makhema JM, Holme MP, Essex M, Alwano MG, Lockman S, Freedberg KAJournal of acquired immune deficiency syndromes (1999)Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):399-407.J Acquir Immune Defic Syndr2022-04-14T00:00:002022Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project.Authorship 1452540935532843Pierce LJ, Regan S, Idigbe I, Adeola J, Musa Z, Ezechi O, Oladeji B, Gureje O, Freedberg KA, Okonkwo P, Ahonkhai AAInternational journal of behavioral medicineAuthor Correction: Psychological Distress Increases 30-Fold Among People with HIV in the First Year on ART in Nigeria-a Call for Integrated Mental Health Services. Int J Behav Med. 2022 Aug; 29(4):530.Int J Behav Med2022-08-01T00:00:002022Author Correction: Psychological Distress Increases 30-Fold Among People with HIV in the First Year on ART in Nigeria-a Call for Integrated Mental Health Services.Authorship 3461596Authorship 35914512Authorship 3609325Authorship 3703321035817068Mohareb AM, Larmarange J, Kim AY, Coffie PA, Kouamé MG, Boyd A, Freedberg KA, Hyle EPThe lancet. HIVRisks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B. Lancet HIV. 2022 08; 9(8):e585-e594.Lancet HIV2022-07-08T00:00:002022Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B.Authorship 14642137Authorship 146824111Authorship 146110614Authorship 1458752935793913Hyle EP, Foote JHA, Shebl FM, Qian Y, Reddy KP, Mukerji SS, Wattananimitgul N, Viswanathan A, Schwamm LH, Pandya A, Freedberg KABMJ openDevelopment and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe. BMJ Open. 2022 07 06; 12(7):e056546.BMJ Open2022-07-06T00:00:002022Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe.35839816Freeman EE, McCann NC, Semeere A, Reddy KP, Laker-Oketta M, Byakwaga H, Pei PP, Hajny Fernandez ME, Kiprono S, Busakhala N, Martin JN, Maurer T, Bassett IV, Freedberg KA, Hyle EPThe Lancet. Global healthEvaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis. Lancet Glob Health. 2022 08; 10(8):e1179-e1188.Lancet Glob Health2022-08-01T00:00:002022Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.35696544Siedner MJ, Alba C, Fitzmaurice KP, Gilbert RF, Scott JA, Shebl FM, Ciaranello A, Reddy KP, Freedberg KAThe Journal of infectious diseasesCost-effectiveness of Coronavirus Disease 2019 Vaccination in Low- and Middle-Income Countries. J Infect Dis. 2022 Nov 28; 226(11):1887-1896.J Infect Dis2022-11-28T00:00:002022Cost-effectiveness of Coronavirus Disease 2019 Vaccination in Low- and Middle-Income Countries.true1Associate Professor of MedicineAssociate Professor of MedicineAuthorship 4202588Authorship 15096091536478076Hyle EP, Kasaie P, Schwamm E, Stewart C, Humes E, Reddy KP, Rebeiro PF, Stanic T, Pei PP, Gerace L, Ang L, Gebo KA, Yu L, Shebl FM, Freedberg KA, Althoff KNThe Journal of infectious diseasesA Growing Number of Men Who Have Sex With Men Aging With HIV (20212031): A Comparison of Two Microsimulation Models. J Infect Dis. 2023 02 01; 227(3):412-422.J Infect Dis2023-02-01T00:00:002023A Growing Number of Men Who Have Sex With Men Aging With HIV (20212031): A Comparison of Two Microsimulation Models.Authorship 151126310Authorship 15147761236604316Dugdale CM, Ufio O, Alba C, Permar SR, Stranix-Chibanda L, Cunningham CK, Fouda GG, Myer L, Weinstein MC, Leroy V, McFarland EJ, Freedberg KA, Ciaranello ALJournal of the International AIDS SocietyCost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings. J Int AIDS Soc. 2023 01; 26(1):e26052.J Int AIDS Soc2023-01-01T00:00:002023Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings.36519674McCann NC, Stanic T, Penazzato M, Flanagan CF, Abrams EJ, Dugdale CM, Johnson LF, Neilan AM, Davies MA, Freedberg KA, Fassinou P, Doherty M, Essajee S, Mushavi A, Soeteman DI, Ciaranello ALJournal of the International AIDS SocietyPrevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmes. J Int AIDS Soc. 2022 12; 25(12):e26045.J Int AIDS Soc2022-12-01T00:00:002022Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmes.true1Professor of MedicineProfessor of MedicineAuthorship 2118573Authorship 1846566Authorship 4921802Authorship 5139628Authorship 15584215Authorship 156471210Authorship 156028013Authorship 1571469837008565Paltiel AD, Ahmed AR, Jin EY, McNamara M, Freedberg KA, Neilan AM, Gonsalves GSOpen forum infectious diseasesIncreased HIV Transmissions With Reduced Insurance Coverage for HIV Preexposure Prophylaxis: Potential Consequences of Braidwood Management v. Becerra. Open Forum Infect Dis. 2023 Mar; 10(3):ofad139.Open Forum Infect Dis2023-03-16T00:00:002023Increased HIV Transmissions With Reduced Insurance Coverage for HIV Preexposure Prophylaxis: Potential Consequences of Braidwood Management v. Becerra.37229763Akoko B, Regan S, Idigbe I, Ezechi O, Pierce LJ, Musa Z, Okonkwo P, Freedberg KA, Ahonkhai AAAIDS careHIV-related stigma and psychological distress in a cohort of patients receiving antiretroviral therapy in Nigeria. AIDS Care. 2024 Feb; 36(2):204-211.AIDS Care2023-05-25T00:00:002023HIV-related stigma and psychological distress in a cohort of patients receiving antiretroviral therapy in Nigeria.37079899Gandhi AR, Hyle EP, Scott JA, Lee JS, Shebl FM, Joska JA, Andersen LS, O'Cleirigh C, Safren SA, Freedberg KAJournal of acquired immune deficiency syndromes (1999)The Clinical Impact and Cost-Effectiveness of Clinic-Based Cognitive Behavioral Therapy for People With HIV, Depression, and Virologic Failure in South Africa. J Acquir Immune Defic Syndr. 2023 08 01; 93(4):333-342.J Acquir Immune Defic Syndr2023-04-04T00:00:002023The Clinical Impact and Cost-Effectiveness of Clinic-Based Cognitive Behavioral Therapy for People With HIV, Depression, and Virologic Failure in South Africa.37308858Luz PM, Deshpande V, Kazemian P, Scott JA, Shebl FM, Spaeth H, Pimenta C, Stern M, Pereira G, Struchiner CJ, Grinsztejn B, Veloso VG, Freedberg KABMC public healthImpact of pre-exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in urban centers in Brazil: a modeling study. BMC Public Health. 2023 06 13; 23(1):1128.BMC Public Health2023-06-13T00:00:002023Impact of pre-exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in urban centers in Brazil: a modeling study.Authorship 3316788Authorship 36795514Authorship 15816879Authorship 15834316Authorship 15826478Authorship 15821771137523048Levison JH, Del Cueto P, Mendoza JV, Ashour D, Lydston M, Freedberg KA, Shebl FMAIDS and behaviorSystematic Review and Meta-analysis of Linkage to HIV Care Interventions in the United States, Canada, and Ukraine (2010-2021). AIDS Behav. 2023 Dec; 27(12):4070-4083.AIDS Behav2023-07-31T00:00:002023Systematic Review and Meta-analysis of Linkage to HIV Care Interventions in the United States, Canada, and Ukraine (2010-2021).37601728Chen W, Gandhi M, Sax PE, Neilan AM, Garland WH, Wilkin T, Cohen R, Ciaranello AL, Kulkarni SP, Eron J, Freedberg KA, Hyle EPOpen forum infectious diseasesProjected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers. Open Forum Infect Dis. 2023 Aug; 10(8):ofad390.Open Forum Infect Dis2023-07-22T00:00:002023Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers.37590260Shebl FM, Qian Y, Foote JHA, Wattananimitgul N, Reddy KP, Neilan AM, Ciaranello AL, Losina E, Freedberg KA, Hyle EPPloS oneThe association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014. PLoS One. 2023; 18(8):e0290113.PLoS One2023-08-17T00:00:002023The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014.37743931Pei PP, Fitzmaurice KP, Le MH, Panella C, Jones ML, Pandya A, Horsburgh CR, Freedberg KA, Weinstein MC, Paltiel AD, Reddy KPMDM policy & practiceThe Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis. MDM Policy Pract. 2023 Jul-Dec; 8(2):23814683231198873.MDM Policy Pract2023-09-22T00:00:002023The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis.Authorship 37895811Authorship 1597253837823865Amick AK, Eskibozkurt GE, Hosek SG, Flanagan CF, Landovitz RJ, Jin EY, Wilson CM, Freedberg KA, Weinstein MC, Kazemian P, Paltiel AD, Ciaranello AL, Neilan AMClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaDaily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price. Clin Infect Dis. 2024 Feb 17; 78(2):402-410.Clin Infect Dis2024-02-17T00:00:002024Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price.Authorship 3989938Authorship 16053682137938475Fung V, Levison JH, Wilson A, Cheng D, Chau C, Krane D, Trieu HD, Irwin K, Cella E, Bird B, Shellenberger K, Silverman P, Batson J, Fathi A, Gamse S, Wolfe J, Holland S, Donelan K, Samuels R, Becker JE, Freedberg KA, Reichman JL, Keller T, Tsai AC, Hsu J, Skotko BG, Bartels SAdministration and policy in mental healthCOVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the Pandemic. Adm Policy Ment Health. 2024 Jan; 51(1):60-68.Adm Policy Ment Health2023-11-08T00:00:002023COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the Pandemic.38015507Rich KM, Pandya A, Chiosi JJ, Reddy KP, Shebl FM, Ciaranello AL, Neilan AM, Pinkney JA, Losina E, Freedberg KA, Ahonkhai AA, Hyle EPJAMA network openProjected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With Men. JAMA Netw Open. 2023 Nov 01; 6(11):e2344385.JAMA Netw Open2023-11-01T00:00:002023Projected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With Men.Authorship 46557811Authorship 160804310Authorship 16102878Authorship 16114201037963069Brenner IR, Simpson KN, Flanagan CF, Dark T, Dooley M, Agwu AL, Koay WLA, Freedberg KA, Ciaranello AL, Neilan AMJournal of the Pediatric Infectious Diseases SocietyProjecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 Pandemic. J Pediatric Infect Dis Soc. 2024 Jan 29; 13(1):60-68.J Pediatric Infect Dis Soc2024-01-29T00:00:002024Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 Pandemic.37986879Alba C, Malhotra S, Horsfall S, Barnhart ME, Bekker A, Chapman K, Cunningham CK, Fast PE, Fouda GG, Freedberg KA, Goga A, Ghazaryan LR, Leroy V, Mann C, McCluskey MM, McFarland EJ, Muturi-Kioi V, Permar SR, Shapiro R, Sok D, Stranix-Chibanda L, Weinstein MC, Ciaranello AL, Dugdale CMmedRxiv : the preprint server for health sciencesCost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study. medRxiv. 2023 Nov 07.medRxiv2023-11-07T00:00:002023Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study.Authorship 1620809938216186Mohareb AM, Kim AY, Boyd A, Noubary F, Kouamé MG, Anglaret X, Coffie PA, Eholie SP, Freedberg KA, Hyle EPBMJ openVirological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model. BMJ Open. 2024 01 12; 14(1):e073498.BMJ Open2024-01-12T00:00:002024Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model.Authorship 16280451238329107Hyle EP, Wattananimitgul N, Mukerji SS, Foote JHA, Reddy KP, Thielking A, Yu L, Viswanathan A, Rubin LH, Shebl FM, Althoff KN, Freedberg KAAIDS (London, England)Age-associated dementia among older people aging with HIV in the US: a modeling study. AIDS. 2024 Feb 08.AIDS2024-02-08T00:00:002024Age-associated dementia among older people aging with HIV in the US: a modeling study.Authorship 16294873Authorship 1631944638406181Keyvanshokooh E, Fattahi M, Freedberg KA, Kazemian PNaval research logisticsMitigating the COVID-19 Pandemic through Data-Driven Resource Sharing. Nav Res Logist. 2024 Feb; 71(1):41-63.Nav Res Logist2023-04-29T00:00:002023Mitigating the COVID-19 Pandemic through Data-Driven Resource Sharing.38369294Luz PM, Spaeth H, Scott JA, Grinsztejn B, Veloso VG, Freedberg KA, Losina EThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious DiseasesVariability in life expectancy among people with HIV in Brazil by gender and sexual orientation. Braz J Infect Dis. 2024 Jan-Feb; 28(1):103722.Braz J Infect Dis2024-02-15T00:00:002024Variability in life expectancy among people with HIV in Brazil by gender and sexual orientation.Authorship 1634563838444112Mohareb AM, Kouamé MG, Nouaman M, Kim AY, Larmarange J, Neilan AM, Lacombe K, Freedberg KA, Boyd A, Coffie P, Hyle EPJournal of the International AIDS SocietyWhat does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic? J Int AIDS Soc. 2024 Mar; 27(3):e26218.J Int AIDS Soc2024-03-01T00:00:002024What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?Authorship 5325269true1Richard Saltonstall Professor of Population Sciences, and Professor of Nutrition, Epidemiology, and Global HealthRichard Saltonstall Professor of Population Sciences, and Professor of Nutrition, Epidemiology, and Global Healthtrue1Professor of MedicineProfessor of Medicinetrue1Professor of the Practice of Public Health and Health PolicyProfessor of the Practice of Public Health and Health Policytrue1Professor of SurgeryProfessor of Surgerytrue1Fellow, Dept/Prog (Stip)Fellow, Dept/Prog (Stip)true1Professor of MedicineProfessor of Medicine2Professor in the Department of Health Policy and ManagementProfessor in the Department of Health Policy and Managementtrue1Professor of MedicineProfessor of MedicineAuthorship 29779610Authorship 3130383Authorship 3695984Authorship 40558510Authorship 4190423Authorship 4402487Authorship 4645018Authorship 349483Authorship 6498869Authorship 64691810Authorship 659333823264445Schackman BR, Haas DW, Becker JE, Berkowitz BK, Sax PE, Daar ES, Ribaudo HJ, Freedberg KAAntiviral therapyCost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease. Antivir Ther. 2013; 18(3):399-408.Antivir Ther2012-12-21T00:00:002012Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease.23741348Venkatesh KK, Becker JE, Kumarasamy N, Nakamura YM, Mayer KH, Losina E, Swaminathan S, Flanigan TP, Walensky RP, Freedberg KAPloS oneClinical impact and cost-effectiveness of expanded voluntary HIV testing in India. PLoS One. 2013; 8(5):e64604.PLoS One2013-05-31T00:00:002013Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.23626808Regan S, Losina E, Chetty S, Giddy J, Walensky RP, Ross D, Holst H, Katz JN, Freedberg KA, Bassett IVPloS oneFactors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa. PLoS One. 2013; 8(4):e62362.PLoS One2013-04-23T00:00:002013Factors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa.Authorship 5285514Authorship 543329Authorship 1878491Authorship 56898011Authorship 673759623303240Orrell C, Levison J, Ciaranello A, Bekker LG, Kuritzkes DR, Freedberg KA, Wood RThe Pediatric infectious disease journalResistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy. Pediatr Infect Dis J. 2013 Jun; 32(6):644-7.Pediatr Infect Dis J2013-06-01T00:00:002013Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy.Authorship 1563237Authorship 6875182024171517Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KAThe New England journal of medicineCost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013 Oct 31; 369(18):1715-25.N Engl J Med2013-10-31T00:00:002013Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.Authorship 3108035Authorship 32751224251725Bassett IV, Regan S, Luthuli P, Mbonambi H, Bearnot B, Pendleton A, Robine M, Mukuvisi D, Thulare H, Walensky RP, Freedberg KA, Losina E, Mhlongo BHIV medicineLinkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa. HIV Med. 2014 Jul; 15(6):367-72.HIV Med2013-11-19T00:00:002013Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa.Authorship 69205510Authorship 691419723972276Bassett IV, Giddy J, Chaisson CE, Ross D, Bogart LM, Coleman SM, Govender T, Robine M, Erlwanger A, Freedberg KA, Katz JN, Walensky RP, Losina EBMC infectious diseasesA randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial. BMC Infect Dis. 2013 Aug 26; 13:390.BMC Infect Dis2013-08-26T00:00:002013A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial.24236170Govindasamy D, Kranzer K, van Schaik N, Noubary F, Wood R, Walensky RP, Freedberg KA, Bassett IV, Bekker LGPloS oneLinkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa. PLoS One. 2013; 8(11):e80017.PLoS One2013-11-13T00:00:002013Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa.Authorship 37921015Authorship 6988651624349503Ciaranello AL, Morris BL, Walensky RP, Weinstein MC, Ayaya S, Doherty K, Leroy V, Hou T, Desmonde S, Lu Z, Noubary F, Patel K, Ramirez-Avila L, Losina E, Seage GR, Freedberg KAPloS oneValidation and calibration of a computer simulation model of pediatric HIV infection. PLoS One. 2013; 8(12):e83389.PLoS One2013-12-13T00:00:002013Validation and calibration of a computer simulation model of pediatric HIV infection.Authorship 6997751524367639Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel ADPloS oneRoutine HIV screening in Portugal: clinical impact and cost-effectiveness. PLoS One. 2013; 8(12):e84173.PLoS One2013-12-18T00:00:002013Routine HIV screening in Portugal: clinical impact and cost-effectiveness.Authorship 2123003Authorship 2416973Authorship 2367305Authorship 706436Authorship 386198424536058Ivers LC, Teng JE, Jerome JG, Bonds M, Freedberg KA, Franke MFClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaA randomized trial of ready-to-use supplementary food versus corn-soy blend plus as food rations for HIV-infected adults on antiretroviral therapy in rural Haiti. Clin Infect Dis. 2014 Apr; 58(8):1176-84.Clin Infect Dis2014-02-17T00:00:002014A randomized trial of ready-to-use supplementary food versus corn-soy blend plus as food rations for HIV-infected adults on antiretroviral therapy in rural Haiti.Authorship 3264703Authorship 1996946Authorship 7172165Authorship 7191137Authorship 71403713Authorship 7208223Authorship 7231974Authorship 7233638Authorship 7253791124332389Drain PK, Hyle EP, Noubary F, Freedberg KA, Wilson D, Bishai WR, Rodriguez W, Bassett IVThe Lancet. Infectious diseasesDiagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2014 Mar; 14(3):239-49.Lancet Infect Dis2013-12-10T00:00:002013Diagnostic point-of-care tests in resource-limited settings.24670522Linas BP, Barter DM, Leff JA, DiLorenzo M, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Freedberg KAAIDS (London, England)The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS. 2014 Jan 28; 28(3):365-76.AIDS2014-01-28T00:00:002014The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients.24307741April MD, Wood R, Berkowitz BK, Paltiel AD, Anglaret X, Losina E, Freedberg KA, Walensky RPThe Journal of infectious diseasesThe survival benefits of antiretroviral therapy in South Africa. J Infect Dis. 2014 Feb 15; 209(4):491-9.J Infect Dis2013-12-03T00:00:002013The survival benefits of antiretroviral therapy in South Africa.24465503Bassett IV, Govindasamy D, Erlwanger AS, Hyle EP, Kranzer K, van Schaik N, Noubary F, Paltiel AD, Wood R, Walensky RP, Losina E, Bekker LG, Freedberg KAPloS oneMobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness. PLoS One. 2014; 9(1):e85197.PLoS One2014-01-22T00:00:002014Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness.24499229Walensky RP, Cohen MS, Freedberg KAThe New England journal of medicineCost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2014 02 06; 370(6):581-2.N Engl J Med2014-02-06T00:00:002014Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.24571362Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Walensky RP, Freedberg KA, Bassett IVBMC infectious diseasesDiagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. BMC Infect Dis. 2014 Feb 26; 14:110.BMC Infect Dis2014-02-26T00:00:002014Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.Authorship 730600724378935Ciaranello A, Lu Z, Ayaya S, Losina E, Musick B, Vreeman R, Freedberg KA, Abrams EJ, Dillabaugh L, Doherty K, Ssali J, Yiannoutsos CT, Wools-Kaloustian KThe Pediatric infectious disease journalIncidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysis. Pediatr Infect Dis J. 2014 Jun; 33(6):623-9.Pediatr Infect Dis J2014-06-01T00:00:002014Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regional analysis.Authorship 7319511024867402McCormick AW, Abuelezam NN, Rhode ER, Hou T, Walensky RP, Pei PP, Becker JE, DiLorenzo MA, Losina E, Freedberg KA, Lipsitch M, Seage GRPloS oneDevelopment, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa. PLoS One. 2014; 9(5):e98272.PLoS One2014-05-27T00:00:002014Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.Authorship 21022512Authorship 3364448Authorship 7426235Authorship 742295424991902Ciaranello AL, Leroy V, Rusibamayila A, Freedberg KA, Shapiro R, Engelsmann B, Lockman S, Kelly KA, Dabis F, Walensky RPAIDS (London, England)Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival. AIDS. 2014 Jul; 28 Suppl 3:S287-99.AIDS2014-07-01T00:00:002014Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival.25024769Levison J, Triant V, Losina E, Keefe K, Freedberg K, Regan SApplied clinical informaticsDevelopment and validation of a computer-based algorithm to identify foreign-born patients with HIV infection from the electronic medical record. Appl Clin Inform. 2014; 5(2):557-70.Appl Clin Inform2014-06-18T00:00:002014Development and validation of a computer-based algorithm to identify foreign-born patients with HIV infection from the electronic medical record.Authorship 3796727Authorship 3800852Authorship 3106793Authorship 381733Authorship 410854Authorship 7456255Authorship 7493141225117965Hyle EP, Naidoo K, Su AE, El-Sadr WM, Freedberg KAJournal of acquired immune deficiency syndromes (1999)HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr. 2014 Sep 01; 67 Suppl 1:S87-95.J Acquir Immune Defic Syndr2014-09-01T00:00:002014HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?24732870Ouattara EN, Ross EL, Yazdanpanah Y, Wong AY, Robine M, Losina E, Moh R, Walensky RP, Danel C, Paltiel AD, Eholié SP, Freedberg KA, Anglaret XJournal of acquired immune deficiency syndromes (1999)Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire. J Acquir Immune Defic Syndr. 2014 Jul 01; 66(3):294-302.J Acquir Immune Defic Syndr2014-07-01T00:00:002014Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.Authorship 756518625206924Cardoso SW, Luz PM, Velasque L, Torres T, Coelho L, Freedberg KA, Veloso VG, Walensky RP, Grinsztejn BAIDS research and therapyEffectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil. AIDS Res Ther. 2014; 11:29.AIDS Res Ther2014-09-01T00:00:002014Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.Authorship 7584831225225800Hyle EP, Jani IV, Lehe J, Su AE, Wood R, Quevedo J, Losina E, Bassett IV, Pei PP, Paltiel AD, Resch S, Freedberg KA, Peter T, Walensky RPPLoS medicineThe clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014 Sep; 11(9):e1001725.PLoS Med2014-09-16T00:00:002014The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.Authorship 609533Authorship 37693310Authorship 41854912Authorship 766159825350957Ross E, Tanser F, Pei P, Newell ML, Losina E, Thiebaut R, Weinstein M, Freedberg K, Anglaret X, Scott C, Dabis F, Walensky RHIV clinical trialsThe impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials. HIV Clin Trials. 2014 Sep-Oct; 15(5):185-98.HIV Clin Trials2014-09-01T00:00:002014The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials.Authorship 84009Authorship 4658495Authorship 2235696Authorship 22432211Authorship 7707721225397616Sax PE, Sypek A, Berkowitz BK, Morris BL, Losina E, Paltiel AD, Kelly KA, Seage GR, Walensky RP, Weinstein MC, Eron J, Freedberg KAPloS oneHIV cure strategies: how good must they be to improve on current antiretroviral therapy? PLoS One. 2014; 9(11):e113031.PLoS One2014-11-14T00:00:002014HIV cure strategies: how good must they be to improve on current antiretroviral therapy?Authorship 2455878Authorship 46668411Authorship 4729696Authorship 774959725291977Schackman BR, Leff JA, Barter DM, DiLorenzo MA, Feaster DJ, Metsch LR, Freedberg KA, Linas BPAddiction (Abingdon, England)Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction. 2015 Jan; 110(1):129-43.Addiction2015-01-01T00:00:002015Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.Authorship 5157219Authorship 777847324729554Paltiel AD, Walensky RP, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaMisinterpretation of HIV preexposure prophylaxis findings. Clin Infect Dis. 2014 Jul 01; 59(1):139-41.Clin Infect Dis2014-04-12T00:00:002014Misinterpretation of HIV preexposure prophylaxis findings.Authorship 5755069Authorship 5451632Authorship 3060442Authorship 5337941Authorship 5751503Authorship 6153612Authorship 643455Authorship 4089511Authorship 3527465Authorship 3541279Authorship 17261810Authorship 5023154Authorship 4676297Authorship 36296310Authorship 473699Authorship 4864007Authorship 2094845Authorship 52443310Authorship 4180054Authorship 722651Authorship 2360974Authorship 2218724Authorship 3353729Authorship 258291525874754Bassett IV, Regan S, Mbonambi H, Blossom J, Bogan S, Bearnot B, Robine M, Walensky RP, Mhlongo B, Freedberg KA, Thulare H, Losina EAIDS and behaviorFinding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South Africa. AIDS Behav. 2015 Oct; 19(10):1888-95.AIDS Behav2015-10-01T00:00:002015Finding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South Africa.Authorship 2445102Authorship 3663942Authorship 3991583Authorship 2614554Authorship 27098911Authorship 32761213Authorship 343275Authorship 12409012Authorship 4310981Authorship 2015194Authorship 2851221Authorship 337431Authorship 3615466Authorship 4670288Authorship 5254761Authorship 26461311Authorship 55403310Authorship 99751Authorship 352756Authorship 2281514Authorship 150896Authorship 2451519Authorship 3045414Authorship 4664692Authorship 5162567Authorship 5308939Authorship 4599165Authorship 3638494Authorship 3196711Authorship 3984425Authorship 45560112Authorship 5606206Authorship 56062113Authorship 78938011Authorship 78786411Authorship 80449712Authorship 8009407Authorship 80053415Authorship 7977824Authorship 80612511Authorship 801173725415289Luz PM, Morris BL, Grinsztejn B, Freedberg KA, Veloso VG, Walensky RP, Losina E, Nakamura YM, Girouard MP, Sax PE, Struchiner CJ, Paltiel ADJournal of acquired immune deficiency syndromes (1999)Cost-effectiveness of genotype testing for primary resistance in Brazil. J Acquir Immune Defic Syndr. 2015 Feb 01; 68(2):152-61.J Acquir Immune Defic Syndr2015-02-01T00:00:002015Cost-effectiveness of genotype testing for primary resistance in Brazil.25734128Cloete C, Regan S, Giddy J, Govender T, Erlwanger A, Gaynes MR, Freedberg KA, Katz JN, Walensky RP, Losina E, Bassett IVOpen forum infectious diseasesThe Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa. Open Forum Infect Dis. 2014 Sep; 1(2):ofu058.Open Forum Infect Dis2014-08-12T00:00:002014The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa.25710311Schackman BR, Fleishman JA, Su AE, Berkowitz BK, Moore RD, Walensky RP, Becker JE, Voss C, Paltiel AD, Weinstein MC, Freedberg KA, Gebo KA, Losina EMedical careThe lifetime medical cost savings from preventing HIV in the United States. Med Care. 2015 Apr; 53(4):293-301.Med Care2015-04-01T00:00:002015The lifetime medical cost savings from preventing HIV in the United States.25583979Ross EL, Weinstein MC, Schackman BR, Sax PE, Paltiel AD, Walensky RP, Freedberg KA, Losina EClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe clinical role and cost-effectiveness of long-acting antiretroviral therapy. Clin Infect Dis. 2015 Apr 01; 60(7):1102-10.Clin Infect Dis2015-01-12T00:00:002015The clinical role and cost-effectiveness of long-acting antiretroviral therapy.25820703Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AYAnnals of internal medicineThe cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 05; 162(9):619-29.Ann Intern Med2015-05-05T00:00:002015The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.25756498Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K, Bekker LG, Hou T, Wood R, Francke JA, Wools-Kaloustian K, Freedberg KA, Walensky RPPloS onePoint-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis. PLoS One. 2015; 10(3):e0117751.PLoS One2015-03-10T00:00:002015Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.25870982Ciaranello AL, Doherty K, Penazzato M, Lindsey JC, Harrison L, Kelly K, Walensky RP, Essajee S, Losina E, Muhe L, Wools-Kaloustian K, Ayaya S, Weinstein MC, Palumbo P, Freedberg KAAIDS (London, England)Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age. AIDS. 2015 Jun 19; 29(10):1247-59.AIDS2015-06-19T00:00:002015Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.Authorship 793664Authorship 3481065Authorship 3468058Authorship 3735514Authorship 4735369Authorship 4814568Authorship 30108710Authorship 815566926180825Cerda R, Perez F, Domingues RM, Luz PM, Grinsztejn B, Veloso VG, Caffe S, Francke JA, Freedberg KA, Ciaranello ALOpen forum infectious diseasesPrenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for Elimination. Open Forum Infect Dis. 2015 Apr; 2(2):ofv073.Open Forum Infect Dis2015-05-22T00:00:002015Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for Elimination.Authorship 3484529Authorship 3537077Authorship 822530725228664Ramirez-Avila L, Regan S, Chetty S, Giddy J, Ross D, Katz JN, Freedberg KA, Losina E, Walensky RP, Bassett IVInternational journal of STD & AIDSHIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years. Int J STD AIDS. 2015 Sep; 26(10):704-9.Int J STD AIDS2014-09-15T00:00:002014HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years.Authorship 42786612Authorship 4400737Authorship 5100707Authorship 5256902Authorship 83368210Authorship 3610526Authorship 838909726424505Ahonkhai AA, Banigbe B, Adeola J, Onwuatuelo I, Bassett IV, Losina E, Freedberg KA, Okonkwo P, Regan SBMC infectious diseasesHigh rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria. BMC Infect Dis. 2015 Sep 30; 15:397.BMC Infect Dis2015-09-30T00:00:002015High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria.Authorship 3851322Authorship 839654426371461Bassett IV, Wilson D, Taaffe J, Freedberg KACurrent opinion in HIV and AIDSFinancial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS. 2015 Nov; 10(6):451-63.Curr Opin HIV AIDS2015-11-01T00:00:002015Financial incentives to improve progression through the HIV treatment cascade.Authorship 845736825958770Drain PK, Kleene JM, Coleman SM, Losina E, Katz JN, Giddy J, Ross D, Freedberg KA, Bassett IVHIV medicinePrevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal. HIV Med. 2015 Nov; 16(10):640-4.HIV Med2015-05-11T00:00:002015Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.Authorship 4503054Authorship 850538526607811Schackman BR, Haas DW, Park SS, Li XC, Freedberg KAPharmacogenomicsCost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice. Pharmacogenomics. 2015 Dec; 16(18):2007-18.Pharmacogenomics2015-11-26T00:00:002015Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Authorship 4217911Authorship 5199106Authorship 5485872Authorship 8581481026651525Pei PP, Weinstein MC, Li XC, Hughes MD, Paltiel AD, Hou T, Parker RA, Gaynes MR, Sax PE, Freedberg KA, Schackman BR, Walensky RPHIV clinical trialsPrioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US. HIV Clin Trials. 2015 Nov; 16(6):207-18.HIV Clin Trials2015-12-11T00:00:002015Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US.Authorship 585552Authorship 862989526658053Girouard MP, Sax PE, Parker RA, Taiwo B, Freedberg KA, Gulick RM, Weinstein MC, Paltiel AD, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States. Clin Infect Dis. 2016 Mar 15; 62(6):784-91.Clin Infect Dis2015-12-09T00:00:002015The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.Authorship 3024959Authorship 37031911Authorship 874807427029828Luz PM, Girouard MP, Grinsztejn B, Freedberg KA, Veloso VG, Losina E, Struchiner CJ, MacLean RL, Parker RA, Paltiel AD, Walensky RPJournal of the International AIDS SocietySurvival benefits of antiretroviral therapy in Brazil: a model-based analysis. J Int AIDS Soc. 2016; 19(1):20623.J Int AIDS Soc2016-03-29T00:00:002016Survival benefits of antiretroviral therapy in Brazil: a model-based analysis.Authorship 877835826681778Walensky RP, Jacobsen MM, Bekker LG, Parker RA, Wood R, Resch SC, Horstman NK, Freedberg KA, Paltiel ADThe Journal of infectious diseasesPotential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection. J Infect Dis. 2016 May 15; 213(10):1523-31.J Infect Dis2015-12-17T00:00:002015Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.Authorship 8813001226936666Ouattara EN, Robine M, Eholié SP, MacLean RL, Moh R, Losina E, Gabillard D, Paltiel AD, Danel C, Walensky RP, Anglaret X, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaLaboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies. Clin Infect Dis. 2016 06 01; 62(11):1454-1462.Clin Infect Dis2016-03-01T00:00:002016Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.Authorship 9132910Authorship 990411Authorship 56586572Assistant Professor1Associate Professor0Full Professor5Other FacultyAuthorship 794941Authorship 8953048Authorship 895404727177151Kimmel AD, Martin EG, Galadima H, Bono RS, Tehrani AB, Cyrus JW, Henderson M, Freedberg KA, Krist AHAIDS careClinical outcomes of HIV care delivery models in the US: a systematic review. AIDS Care. 2016 10; 28(10):1215-22.AIDS Care2016-05-13T00:00:002016Clinical outcomes of HIV care delivery models in the US: a systematic review.27416841Abuelezam NN, McCormick AW, Fussell T, Afriyie AN, Wood R, DeGruttola V, Freedberg KA, Lipsitch M, Seage GRAmerican journal of epidemiologyCan the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis. Am J Epidemiol. 2016 08 01; 184(3):239-48.Am J Epidemiol2016-07-13T00:00:002016Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.27469972Levison JH, Regan S, Khan I, Freedberg KAAIDS careForeign-born status as a predictor of engagement in HIV care in a large US metropolitan health system. AIDS Care. 2017 02; 29(2):244-251.AIDS Care2016-07-28T00:00:002016Foreign-born status as a predictor of engagement in HIV care in a large US metropolitan health system.Authorship 635985Authorship 9083741027329680Ahonkhai AA, Banigbe B, Adeola J, Adegoke AB, Regan S, Bassett IV, Idigbe I, Losina E, Okonkwo P, Freedberg KAThe Journal of adolescent health : official publication of the Society for Adolescent MedicineAge Matters: Increased Risk of Inconsistent HIV Care and Viremia Among Adolescents and Young Adults on Antiretroviral Therapy in Nigeria. J Adolesc Health. 2016 09; 59(3):298-304.J Adolesc Health2016-06-18T00:00:002016Age Matters: Increased Risk of Inconsistent HIV Care and Viremia Among Adolescents and Young Adults on Antiretroviral Therapy in Nigeria.Authorship 573962131998-07-31FREEDBERG, KENNETH ALAN1994-08-01COST-EFFECTIVENESS OF PREVENTING AIDS COMPLICATIONSR01HS0073172025-07-31FREEDBERG, KENNETH ALAN1998-04-01Cost-Effectiveness of Preventing HIV ComplicationsR01AI0420062015-07-31FREEDBERG, KENNETH ALAN1998-04-01Cost-effectiveness of preventing HIV complicationsR37AI0420062027-06-30FREEDBERG, KENNETH ALAN1992-09-30Program for AIDS Clinical Research Training (PACRT)T32AI0074332018-07-31FREEDBERG, KENNETH ALAN2003-09-01Optimizing HIV Care in Less Developed CountriesR01AI0587362009-07-31FREEDBERG, KENNETH ALAN2004-08-01Optimal Strategies for Management of HIV DiseaseK24AI0624762024-07-31GANDHI, RAJESH T2004-07-01Harvard University Center for AIDS ResearchP30AI0603542003-03-31FREEDBERG, KENNETH ALAN1997-09-30Cost Effectiveness of Preventing HIV ComplicationsR21AI042006Principal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorCo-Principal InvestigatorAuthorship 911719927240120Walensky RP, Borre ED, Bekker LG, Resch SC, Hyle EP, Wood R, Weinstein MC, Ciaranello AL, Freedberg KA, Paltiel ADAnnals of internal medicineThe Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. Ann Intern Med. 2016 09 06; 165(5):325-33.Ann Intern Med2016-05-31T00:00:002016The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.Authorship 688464Authorship 9152551027632145Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Jacobsen MM, Robine M, Govender T, Freedberg KA, Katz JN, Walensky RP, Losina EJournal of acquired immune deficiency syndromes (1999)Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa. J Acquir Immune Defic Syndr. 2016 Oct 01; 73(2):154-60.J Acquir Immune Defic Syndr2016-10-01T00:00:002016Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa.Authorship 9032427677161Mukherjee PK, Chen H, Patton LL, Evans S, Lee A, Kumwenda J, Hakim J, Masheto G, Sawe F, Pho MT, Freedberg KA, Shiboski CH, Ghannoum MA, Salata RAAIDS (London, England)Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. AIDS. 2017 01 02; 31(1):81-88.AIDS2017-01-02T00:00:002017Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.27815384Reddy KP, Parker RA, Losina E, Baggett TP, Paltiel AD, Rigotti NA, Weinstein MC, Freedberg KA, Walensky RPThe Journal of infectious diseasesImpact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study. J Infect Dis. 2016 Dec 01; 214(11):1672-1681.J Infect Dis2016-11-03T00:00:002016Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.Authorship 92012611Authorship 430194Authorship 5164376Authorship 5360549Authorship 92968211Authorship 9302098Authorship 934178127540110Francke JA, Penazzato M, Hou T, Abrams EJ, MacLean RL, Myer L, Walensky RP, Leroy V, Weinstein MC, Parker RA, Freedberg KA, Ciaranello AThe Journal of infectious diseasesClinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency. J Infect Dis. 2016 Nov 01; 214(9):1319-1328.J Infect Dis2016-08-17T00:00:002016Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency.26878073Freedberg KA, Possas C, Deeks S, Ross AL, Rosettie KL, Di Mascio M, Collins C, Walensky RP, Yazdanpanah YJournal of virus eradicationThe HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis. J Virus Erad. 2015; 1(4):245-249.J Virus Erad2015-09-27T00:00:002015The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis.Authorship 2797018Authorship 2992322Authorship 9403684Authorship 940282127920163Freedberg KA, Sax PEJournal of medical ethicsImproving on effective antiretroviral therapy: how good will a cure have to be? J Med Ethics. 2017 02; 43(2):71-73.J Med Ethics2016-12-05T00:00:002016Improving on effective antiretroviral therapy: how good will a cure have to be?Authorship 3865848Authorship 4448168Authorship 4516822Authorship 9474871028060226Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Flash MJ, Govender T, Walensky RP, Freedberg KA, Losina EJournal of acquired immune deficiency syndromes (1999)Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa. J Acquir Immune Defic Syndr. 2017 04 01; 74(4):432-438.J Acquir Immune Defic Syndr2017-04-01T00:00:002017Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa.Authorship 949064828084189Ahonkhai AA, Adeola J, Banigbe B, Onwuatuelo I, Adegoke AB, Bassett IV, Losina E, Freedberg KA, Okonkwo P, Regan SJournal of the International Association of Providers of AIDS CareImpact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort. J Int Assoc Provid AIDS Care. 2017 Jan/Feb; 16(1):98-104.J Int Assoc Provid AIDS Care2016-10-10T00:00:002016Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort.Authorship 5037531Authorship 5363994Authorship 699119Authorship 70941610186457Freedberg KA, Paltiel ADPharmacoEconomicsCost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion. Pharmacoeconomics. 1998 Aug; 14(2):165-74.Pharmacoeconomics1998-08-01T00:00:001998Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion.10534637Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HKJournal of the American Academy of DermatologyScreening for malignant melanoma: A cost-effectiveness analysis. J Am Acad Dermatol. 1999 Nov; 41(5 Pt 1):738-45.J Am Acad Dermatol1999-11-01T00:00:001999Screening for malignant melanoma: A cost-effectiveness analysis.11961477Johri M, David Paltiel A, Goldie SJ, Freedberg KAMedical careState AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards. Med Care. 2002 May; 40(5):429-41.Med Care2002-05-01T00:00:002002State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards.12074264Wu AW, Jacobson KL, Frick KD, Clark R, Revicki DA, Freedberg KA, Scott-Lennox J, Feinberg JQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationValidity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res. 2002 May; 11(3):273-82.Qual Life Res2002-05-01T00:00:002002Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial.12138349Seage GR, Losina E, Goldie SJ, Paltiel AD, Kimmel AD, Freedberg KAJournal of acquired immune deficiency syndromes (1999)The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality. J Acquir Immune Defic Syndr. 2002 Aug 01; 30(4):421-8.J Acquir Immune Defic Syndr2002-08-01T00:00:002002The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality.14689354Pincus JM, Crosby SS, Losina E, King ER, LaBelle C, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAcute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin Infect Dis. 2003 Dec 15; 37(12):1699-704.Clin Infect Dis2003-11-17T00:00:002003Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center.15156451Losina E, Islam R, Pollock AC, Sax PE, Freedberg KA, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaEffectiveness of antiretroviral therapy after protease inhibitor failure: an analytic overview. Clin Infect Dis. 2004 Jun 01; 38(11):1613-22.Clin Infect Dis2004-05-13T00:00:002004Effectiveness of antiretroviral therapy after protease inhibitor failure: an analytic overview.16206108Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaShould resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis. 2005 Nov 01; 41(9):1316-23.Clin Infect Dis2005-09-23T00:00:002005Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.16547789Mrus JM, Schackman BR, Wu AW, Freedberg KA, Tsevat J, Yi MS, Zackin RQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationVariations in self-rated health among patients with HIV infection. Qual Life Res. 2006 Apr; 15(3):503-14.Qual Life Res2006-04-01T00:00:002006Variations in self-rated health among patients with HIV infection.11527782Schackman BR, Goldie SJ, Weinstein MC, Losina E, Zhang H, Freedberg KAAmerican journal of public healthCost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults. Am J Public Health. 2001 Sep; 91(9):1456-63.Am J Public Health2001-09-01T00:00:002001Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults.Authorship 967305628192387Ramirez-Avila L, Regan S, Cloete C, Crankshaw T, Rabideau DJ, Freedberg KA, Parker RA, Walensky RP, Losina E, Bassett IVThe Pediatric infectious disease journalAdolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa. Pediatr Infect Dis J. 2017 03; 36(3):311-313.Pediatr Infect Dis J2017-03-01T00:00:002017Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa.10155305Freedberg KAPharmacoEconomicsClinical and economic aspects of prophylaxis and treatment of Pneumocystis carinii pneumonia. Pharmacoeconomics. 1995 Feb; 7(2):95-8.Pharmacoeconomics1995-02-01T00:00:001995Clinical and economic aspects of prophylaxis and treatment of Pneumocystis carinii pneumonia.17366461McCormick AW, Walensky RP, Lipsitch M, Losina E, Hsu H, Weinstein MC, Paltiel AD, Freedberg KA, Seage GRClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaThe effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis. 2007 Apr 15; 44(8):1115-22.Clin Infect Dis2007-03-09T00:00:002007The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men.9292586Freedberg KA, Cohen CJ, Barber TWJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology AssociationProphylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS: a cost-effectiveness analysis. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 01; 15(4):275-82.J Acquir Immune Defic Syndr Hum Retrovirol1997-08-01T00:00:001997Prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS: a cost-effectiveness analysis.11462197Walensky RP, Rosenberg ES, Ferraro MJ, Losina E, Walker BD, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaInvestigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody. Clin Infect Dis. 2001 Aug 15; 33(4):570-2.Clin Infect Dis2001-07-20T00:00:002001Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody.11498068Goldie SJ, Freedberg KA, Weinstein MC, Wright TC, Kuntz KMThe American journal of medicineCost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med. 2001 Aug; 111(2):140-9.Am J Med2001-08-01T00:00:002001Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.11511618Yazdanpanah Y, Chêne G, Losina E, Goldie SJ, Merchadou LD, Alfandari S, Seage GR, Sullivan L, Marimoutou C, Paltiel AD, Salamon R, Mouton Y, Freedberg KAInternational journal of epidemiologyIncidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Int J Epidemiol. 2001 Aug; 30(4):864-71.Int J Epidemiol2001-08-01T00:00:002001Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.19193111Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR, Sloan CE, Sax PE, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis. 2009 Mar 15; 48(6):806-15.Clin Infect Dis2009-03-15T00:00:002009HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.Authorship 972032828329243Parker RA, Rabideau DJ, Sax PE, Tierney C, Daar ES, Collier AC, Losina E, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaImpact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study. Clin Infect Dis. 2017 Jun 01; 64(11):1612-1614.Clin Infect Dis2017-06-01T00:00:002017Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.11833663Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J, Weinstein MCMedical decision making : an international journal of the Society for Medical Decision MakingComparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making. 2002 Jan-Feb; 22(1):27-38.Med Decis Making2002-01-01T00:00:002002Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS.1673157Freedberg KA, Tosteson AN, Cohen CJ, Cotton DJJournal of acquired immune deficiency syndromesPrimary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. J Acquir Immune Defic Syndr (1988). 1991; 4(5):521-31.J Acquir Immune Defic Syndr (1988)1991-01-01T00:00:001991Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis.12491207Yazdanpanah Y, Goldie SJ, Paltiel AD, Losina E, Coudeville L, Weinstein MC, Gerard Y, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPrevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. Clin Infect Dis. 2003 Jan 01; 36(1):86-96.Clin Infect Dis2002-12-11T00:00:002002Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis.15751766Samet JH, Horton NJ, Meli S, Dukes K, Tripps T, Sullivan L, Freedberg KAAntiviral therapyA randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005; 10(1):83-93.Antivir Ther2005-01-01T00:00:002005A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems.1351940Freedberg KA, Tosteson AN, Cotton DJ, Goldman LJournal of general internal medicineOptimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis. J Gen Intern Med. 1992 May-Jun; 7(3):261-72.J Gen Intern Med1992-05-01T00:00:001992Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.9440663Freedberg KA, Scharfstein JA, Seage GR, Losina E, Weinstein MC, Craven DE, Paltiel ADJAMAThe cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA. 1998 Jan 14; 279(2):130-6.JAMA1998-01-14T00:00:001998The cost-effectiveness of preventing AIDS-related opportunistic infections.11255519Weinstein MC, Goldie SJ, Losina E, Cohen CJ, Baxter JD, Zhang H, Kimmel AD, Freedberg KAAnnals of internal medicineUse of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness. Ann Intern Med. 2001 Mar 20; 134(6):440-50.Ann Intern Med2001-03-20T00:00:002001Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness.12352147Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR, Losina E, Zhang H, Islam R, Freedberg KAJournal of acquired immune deficiency syndromes (1999)Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. J Acquir Immune Defic Syndr. 2002 Sep 01; 31(1):27-37.J Acquir Immune Defic Syndr2002-09-01T00:00:002002Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy.16670217Linas BP, Zheng H, Losina E, Walensky RP, Freedberg KAAmerican journal of public healthAssessing the impact of federal HIV prevention spending on HIV testing and awareness. Am J Public Health. 2006 Jun; 96(6):1038-43.Am J Public Health2006-05-02T00:00:002006Assessing the impact of federal HIV prevention spending on HIV testing and awareness.16841136Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, Seage GR, N'Dri-Yoman T, Walensky RP, Dakoury-Dogbo N, Goldie SJ, Messou E, Weinstein MC, Deuffic-Burban S, Salamon R, Freedberg KASouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskundeImpact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J. 2006 Jun; 96(6):526-9.S Afr Med J2006-06-01T00:00:002006Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.9554679Samet JH, Freedberg KA, Stein MD, Lewis R, Savetsky J, Sullivan L, Levenson SM, Hingson RArchives of internal medicineTrillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med. 1998 Apr 13; 158(7):734-40.Arch Intern Med1998-04-13T00:00:001998Trillion virion delay: time from testing positive for HIV to presentation for primary care.10068381Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KAAnnals of internal medicineThe costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med. 1999 Jan 19; 130(2):97-107.Ann Intern Med1999-01-19T00:00:001999The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.11966339Walensky RP, Losina E, Steger-Craven KA, Freedberg KAArchives of internal medicineIdentifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med. 2002 Apr 22; 162(8):887-92.Arch Intern Med2002-04-22T00:00:002002Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing.11966344Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KAArchives of internal medicineProphylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines. Arch Intern Med. 2002 Apr 22; 162(8):921-8.Arch Intern Med2002-04-22T00:00:002002Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.12553480Yazdanpanah Y, Goldie SJ, Losina E, Weinstein MC, Lebrun T, Paltiel AD, Seage GR, Leblanc G, Ajana F, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KAAntiviral therapyLifetime cost of HIV care in France during the era of highly active antiretroviral therapy. Antivir Ther. 2002 Dec; 7(4):257-66.Antivir Ther2002-12-01T00:00:002002Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.10405693Samet JH, Muz P, Cabral P, Jhamb K, Suwanchinda A, Freedberg KAMayo Clinic proceedingsDermatologic manifestations in HIV-infected patients: a primary care perspective. Mayo Clin Proc. 1999 Jul; 74(7):658-60.Mayo Clin Proc1999-07-01T00:00:001999Dermatologic manifestations in HIV-infected patients: a primary care perspective.22253579Ciaranello AL, Perez F, Keatinge J, Park JE, Engelsmann B, Maruva M, Walensky RP, Dabis F, Chu J, Rusibamayila A, Mushavi A, Freedberg KAPLoS medicineWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis. PLoS Med. 2012 Jan; 9(1):e1001156.PLoS Med2012-01-10T00:00:002012What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.22451351Ramirez-Avila L, Regan S, Giddy J, Chetty S, Ross D, Katz JN, Freedberg KA, Walensky RP, Losina E, Bassett IVAIDS and behaviorDepressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav. 2012 Nov; 16(8):2226-35.AIDS Behav2012-11-01T00:00:002012Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa.12437408Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJArchives of internal medicineCost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Arch Intern Med. 2002 Nov 25; 162(21):2478-86.Arch Intern Med2002-11-25T00:00:002002Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.17457091Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, Mercincavage LM, Touré S, Divi N, Anglaret X, Goldie SJ, Freedberg KAAIDS (London, England)HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS. 2007 May 11; 21(8):973-82.AIDS2007-05-11T00:00:002007HIV drug resistance surveillance for prioritizing treatment in resource-limited settings.9343795Scharfstein JA, Paltiel AD, Freedberg KAMedical decision making : an international journal of the Society for Medical Decision MakingThe cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients. Med Decis Making. 1997 Oct-Dec; 17(4):373-81.Med Decis Making1997-10-01T00:00:001997The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.10874380Scharfstein JA, Paltiel AD, Weinstein MC, Seage GR, Losina E, Craven DE, Freedberg KAInternational journal of technology assessment in health careThe cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS. Int J Technol Assess Health Care. 1999; 15(3):531-47.Int J Technol Assess Health Care1999-01-01T00:00:001999The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS.15751762Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KAAntiviral therapyOptimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients. Antivir Ther. 2005; 10(1):41-52.Antivir Ther2005-01-01T00:00:002005Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.16052085Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KAAIDS (London, England)Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. AIDS. 2005 Aug 12; 19(12):1299-308.AIDS2005-08-12T00:00:002005Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.10510984Freedberg KA, Samet JHArchives of internal medicineThink HIV: why physicians should lower their threshold for HIV testing. Arch Intern Med. 1999 Sep 27; 159(17):1994-2000.Arch Intern Med1999-09-27T00:00:001999Think HIV: why physicians should lower their threshold for HIV testing.10856411Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JMThe American journal of medicineCost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med. 2000 Jun 01; 108(8):634-41.Am J Med2000-06-01T00:00:002000Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.14513418Hanna GJ, Balaguera HU, Freedberg KA, Werner BG, Steger Craven KA, Craven DE, D'Aquila RTThe Journal of infectious diseasesDrug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection. J Infect Dis. 2003 Oct 01; 188(7):986-91.J Infect Dis2003-09-10T00:00:002003Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection.Authorship 9812841028480259Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AYOpen forum infectious diseasesCost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2017; 4(1):ofw266.Open Forum Infect Dis2016-12-27T00:00:002016Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1.18190295Walensky RP, Freedberg KA, Weinstein MC, Paltiel ADClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis. 2007 Dec 15; 45 Suppl 4:S248-54.Clin Infect Dis2007-12-15T00:00:002007Cost-effectiveness of HIV testing and treatment in the United States.12173137Walensky RP, Paltiel AD, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States. Clin Infect Dis. 2002 Sep 01; 35(5):606-10.Clin Infect Dis2002-08-02T00:00:002002AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States.19504725Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, Lu Z, Losina E, Walensky RP, Freedberg KAJournal of acquired immune deficiency syndromes (1999)Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009 Jun 01; 51(2):135-9.J Acquir Immune Defic Syndr2009-06-01T00:00:002009Loss to care and death before antiretroviral therapy in Durban, South Africa.39211Freedberg KA, Innis RB, Creese I, Snyder SHLife sciencesAntischizophrenic drugs: differential plasma protein binding and therapeutic activity. Life Sci. 1979 Jun 25; 24(26):2467-73.Life Sci1979-06-25T00:00:001979Antischizophrenic drugs: differential plasma protein binding and therapeutic activity.19845472Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaRacial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis. 2009 Nov 15; 49(10):1570-8.Clin Infect Dis2009-11-15T00:00:002009Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.12922090Hanslik T, Boëlle PY, Schwarzinger M, Carrat F, Freedberg KA, Valleron AJ, Flahault AVaccineVaricella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination. Vaccine. 2003 Sep 08; 21(25-26):3614-22.Vaccine2003-09-08T00:00:002003Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.21126955Sax PE, Sloan CE, Schackman BR, Grant PM, Rong J, Zolopa AR, Powderly W, Losina E, Freedberg KAHIV clinical trialsEarly antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. HIV Clin Trials. 2010 Sep-Oct; 11(5):248-59.HIV Clin Trials2010-09-01T00:00:002010Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.17453588Louis C, Ivers LC, Smith Fawzi MC, Freedberg KA, Castro AAIDS careLate presentation for HIV care in central Haiti: factors limiting access to care. AIDS Care. 2007 Apr; 19(4):487-91.AIDS Care2007-04-01T00:00:002007Late presentation for HIV care in central Haiti: factors limiting access to care.17879926Schackman BR, Scott CA, Sax PE, Losina E, Wilkin TJ, McKinnon JE, Swindells S, Weinstein MC, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPotential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clin Infect Dis. 2007 Oct 15; 45(8):1062-70.Clin Infect Dis2007-09-04T00:00:002007Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.16810113Holmes CB, Wood R, Badri M, Zilber S, Wang B, Maartens G, Zheng H, Lu Z, Freedberg KA, Losina EJournal of acquired immune deficiency syndromes (1999)CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr. 2006 Aug 01; 42(4):464-9.J Acquir Immune Defic Syndr2006-08-01T00:00:002006CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.17051505Linas BP, Zheng H, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaOptimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis. 2006 Nov 15; 43(10):1357-64.Clin Infect Dis2006-10-17T00:00:002006Optimizing resource allocation in United States AIDS drug assistance programs.17106280Robbins GK, Daniels B, Zheng H, Chueh H, Meigs JB, Freedberg KAJournal of acquired immune deficiency syndromes (1999)Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr. 2007 Jan 01; 44(1):30-7.J Acquir Immune Defic Syndr2007-01-01T00:00:002007Predictors of antiretroviral treatment failure in an urban HIV clinic.Authorship 9895571028605504Losina E, Hyle EP, Borre ED, Linas BP, Sax PE, Weinstein MC, Rusu C, Ciaranello AL, Walensky RP, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaProjecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017 10 15; 65(8):1266-1271.Clin Infect Dis2017-10-15T00:00:002017Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States.18156991Valerio L, Yazdanpanah Y, Poizot-Martin I, Rosenthal E, Marimoutou C, Gastaut JA, Tran A, Dellamonica P, Freedberg KA, Pradier CJournal of acquired immune deficiency syndromes (1999)Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr. 2008 Jan 01; 47(1):50-5.J Acquir Immune Defic Syndr2008-01-01T00:00:002008Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.11229847Paltiel AD, Goldie SJ, Losina E, Weinstein MC, Seage GR, Kimmel AD, Zhang H, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPreevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus. Clin Infect Dis. 2001 Mar 01; 32(5):783-93.Clin Infect Dis2001-02-28T00:00:002001Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus.19362992Ciaranello AL, Walensky RP, Sax PE, Chang Y, Freedberg KA, Weissman JSHIV clinical trialsAccess to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents. HIV Clin Trials. 2009 Jan-Feb; 10(1):13-24.HIV Clin Trials2009-01-01T00:00:002009Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.50 Staniford StreetMassachusetts General HospitalDiv. of General Internal Medicine, 9th Floor50 Staniford StreetBoston02114MA21178419Williams-Roberts H, Chang Y, Losina E, Freedberg KA, Walensky RPVirulenceFrequent HIV testing among participants of a routine HIV testing program. Virulence. 2010 Mar-Apr; 1(2):68-71.Virulence2010-03-01T00:00:002010Frequent HIV testing among participants of a routine HIV testing program.15100608Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu AAlcoholism, clinical and experimental researchAlcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004 Apr; 28(4):572-7.Alcohol Clin Exp Res2004-04-01T00:00:002004Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.Authorship 9981206Authorship 997876928680903Paltiel AD, Zheng A, Weinstein MC, Gaynes MR, Wood R, Freedberg KA, Sax PE, Walensky RPOpen forum infectious diseasesSetting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa. Open Forum Infect Dis. 2017; 4(2):ofx081.Open Forum Infect Dis2017-04-22T00:00:002017Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa.28692541Hyle EP, Jani IV, Rosettie KL, Wood R, Osher B, Resch S, Pei PP, Maggiore P, Freedberg KA, Peter T, Parker RA, Walensky RPAIDS (London, England)The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations. AIDS. 2017 Jul 07.AIDS2017-07-07T00:00:002017The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations.15703423Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, Freedberg KA, Walensky RPThe New England journal of medicineExpanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med. 2005 Feb 10; 352(6):586-95.N Engl J Med2005-02-10T00:00:002005Expanded screening for HIV in the United States--an analysis of cost-effectiveness.17063130Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR, Moore RD, Freedberg KAMedical careThe lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006 Nov; 44(11):990-7.Med Care2006-11-01T00:00:002006The lifetime cost of current human immunodeficiency virus care in the United States.20043752Bender MA, Kumarasamy N, Mayer KH, Wang B, Walensky RP, Flanigan T, Schackman BR, Scott CA, Lu Z, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCost-effectiveness of tenofovir as first-line antiretroviral therapy in India. Clin Infect Dis. 2010 Feb 01; 50(3):416-25.Clin Infect Dis2010-02-01T00:00:002010Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.9472205Stein MD, Freedberg KA, Sullivan LM, Savetsky J, Levenson SM, Hingson R, Samet JHArchives of internal medicineSexual ethics. Disclosure of HIV-positive status to partners. Arch Intern Med. 1998 Feb 09; 158(3):253-7.Arch Intern Med1998-02-09T00:00:001998Sexual ethics. Disclosure of HIV-positive status to partners.10770917Gross PA, Asch S, Kitahata MM, Freedberg KA, Barr D, Melnick DA, Bozzette SA, Bozette SAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPerformance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus. Clin Infect Dis. 2000 Apr; 30 Suppl 1:S85-93.Clin Infect Dis2000-04-01T00:00:002000Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus.17146064Paltiel AD, Walensky RP, Schackman BR, Seage GR, Mercincavage LM, Weinstein MC, Freedberg KAAnnals of internal medicineExpanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006 Dec 05; 145(11):797-806.Ann Intern Med2006-12-05T00:00:002006Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.17706448Losina E, Figueroa P, Duncan J, Divi N, Wolf LL, Hirschhorn LR, Robertson M, Harvey K, Whorms S, Freedberg KA, Gebre YInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesHIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005. Int J Infect Dis. 2008 Mar; 12(2):132-8.Int J Infect Dis2007-08-13T00:00:002007HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005.21191309Messou E, Chaix ML, Gabillard D, Minga A, Losina E, Yapo V, Kouakou M, Danel C, Sloan C, Rouzioux C, Freedberg KA, Anglaret XJournal of acquired immune deficiency syndromes (1999)Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire. J Acquir Immune Defic Syndr. 2011 Apr; 56(4):356-64.J Acquir Immune Defic Syndr2011-04-01T00:00:002011Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.21900717Levison JH, Orrell C, Losina E, Lu Z, Freedberg KA, Wood RAntiviral therapyEarly outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa. Antivir Ther. 2011; 16(6):853-61.Antivir Ther2011-01-01T00:00:002011Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa.23208165Robbins GK, Lester W, Johnson KL, Chang Y, Estey G, Surrao D, Zachary K, Lammert SM, Chueh HC, Meigs JB, Freedberg KAAnnals of internal medicineEfficacy of a clinical decision-support system in an HIV practice: a randomized trial. Ann Intern Med. 2012 Dec 04; 157(11):757-66.Ann Intern Med2012-12-04T00:00:002012Efficacy of a clinical decision-support system in an HIV practice: a randomized trial.20796284Ivers LC, Chang Y, Gregory Jerome J, Freedberg KAAIDS research and therapyFood assistance is associated with improved body mass index, food security and attendance at clinic in an HIV program in central Haiti: a prospective observational cohort study. AIDS Res Ther. 2010 Aug 26; 7:33.AIDS Res Ther2010-08-26T00:00:002010Food assistance is associated with improved body mass index, food security and attendance at clinic in an HIV program in central Haiti: a prospective observational cohort study.20844741Rydzak CE, Cotich KL, Sax PE, Hsu HE, Wang B, Losina E, Freedberg KA, Weinstein MC, Goldie SJPloS oneAssessing the performance of a computer-based policy model of HIV and AIDS. PLoS One. 2010 Sep 09; 5(9).PLoS One2010-09-09T00:00:002010Assessing the performance of a computer-based policy model of HIV and AIDS.Authorship 10067894Authorship 10079001028838064Murray EJ, Robins JM, Seage GR, Freedberg KA, Hernán MAAmerican journal of epidemiologyA Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference. Am J Epidemiol. 2017 Jul 15; 186(2):131-142.Am J Epidemiol2017-07-15T00:00:002017A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.28847013Walensky RP, Borre ED, Bekker LG, Hyle EP, Gonsalves GS, Wood R, Eholié SP, Weinstein MC, Anglaret X, Freedberg KA, Paltiel ADAnnals of internal medicineDo Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid. Ann Intern Med. 2017 Nov 07; 167(9):618-629.Ann Intern Med2017-08-29T00:00:002017Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.Authorship 1009948928906279Hyle EP, Jani IV, Rosettie KL, Wood R, Osher B, Resch S, Pei PP, Maggiore P, Freedberg KA, Peter T, Parker RA, Walensky RPAIDS (London, England)The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. AIDS. 2017 09 24; 31(15):2135-2145.AIDS2017-09-24T00:00:002017The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.15851916Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RPJournal of acquired immune deficiency syndromes (1999)Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. J Acquir Immune Defic Syndr. 2005 May 01; 39(1):69-77.J Acquir Immune Defic Syndr2005-05-01T00:00:002005Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease.19663693Brumme Z, Wang B, Nair K, Brumme C, de Pierres C, Reddy S, Julg B, Moodley E, Thobakgale C, Lu Z, van der Stok M, Bishop K, Mncube Z, Chonco F, Yuki Y, Frahm N, Brander C, Carrington M, Freedberg K, Kiepiela P, Goulder P, Walker B, Ndung'u T, Losina EClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaImpact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa. Clin Infect Dis. 2009 Sep 15; 49(6):956-64.Clin Infect Dis2009-09-15T00:00:002009Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.20546501Linas BP, Wang B, Smurzynski M, Losina E, Bosch RJ, Schackman BR, Rong J, Sax PE, Walensky RP, Schouten J, Freedberg KAJournal of viral hepatitisThe impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. J Viral Hepat. 2011 Jul; 18(7):506-12.J Viral Hepat2010-06-09T00:00:002010The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort.20553336Bassett IV, Chetty S, Giddy J, Reddy S, Bishop K, Lu Z, Losina E, Freedberg KA, Walensky RPHIV medicineScreening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med. 2011 Jan; 12(1):46-53.HIV Med2011-01-01T00:00:002011Screening for acute HIV infection in South Africa: finding acute and chronic disease.28975270Reddy KP, Kong CY, Hyle EP, Baggett TP, Huang M, Parker RA, Paltiel AD, Losina E, Weinstein MC, Freedberg KA, Walensky RPJAMA internal medicineLung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States. JAMA Intern Med. 2017 11 01; 177(11):1613-1621.JAMA Intern Med2017-11-01T00:00:002017Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States.23176556Ahonkhai AA, Bassett IV, Ferris TG, Freedberg KABMC health services researchImproving HIV outcomes in resource-limited countries: the importance of quality indicators. BMC Health Serv Res. 2012 Nov 24; 12:427.BMC Health Serv Res2012-11-24T00:00:002012Improving HIV outcomes in resource-limited countries: the importance of quality indicators.Authorship 101644910Authorship 1015643728979922Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Freedberg KA, Bassett IVOpen forum infectious diseasesClinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa. Open Forum Infect Dis. 2017; 4(3):ofx167.Open Forum Infect Dis2017-08-14T00:00:002017Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa.16741877Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KAThe Journal of infectious diseasesThe survival benefits of AIDS treatment in the United States. J Infect Dis. 2006 Jul 01; 194(1):11-9.J Infect Dis2006-06-01T00:00:002006The survival benefits of AIDS treatment in the United States.Authorship 10179456Authorship 10187301028992154Ahonkhai AA, Onwuatuelo I, Regan S, Adegoke A, Losina E, Banigbe B, Adeola J, Ferris TG, Okonkwo P, Freedberg KAInternational journal for quality in health care : journal of the International Society for Quality in Health CareThe patient-centered medical home: a reality for HIV care in Nigeria. Int J Qual Health Care. 2017 Oct 01; 29(5):654-661.Int J Qual Health Care2017-10-01T00:00:002017The patient-centered medical home: a reality for HIV care in Nigeria.29029344Borre ED, Hyle EP, Paltiel AD, Neilan AM, Sax PE, Freedberg KA, Weinstein MC, Walensky RPThe Journal of infectious diseasesThe Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States. J Infect Dis. 2017 10 17; 216(7):798-807.J Infect Dis2017-10-17T00:00:002017The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.15745728Walensky RP, Weinstein MC, Kimmel AD, Seage GR, Losina E, Sax PE, Zhang H, Smith HE, Freedberg KA, Paltiel ADThe American journal of medicineRoutine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005 Mar; 118(3):292-300.Am J Med2005-03-01T00:00:002005Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.16798621Wertheimer BZ, Freedberg KA, Walensky RP, Yazdanapah Y, Losina EHIV clinical trialsTherapeutic drug monitoring in HIV treatment: a literature review. HIV Clin Trials. 2006 Mar-Apr; 7(2):59-69.HIV Clin Trials2006-03-01T00:00:002006Therapeutic drug monitoring in HIV treatment: a literature review.16897416Liddicoat RV, Zheng H, Internicola J, Werner BG, Kazianis A, Golan Y, Rubinstein EP, Freedberg KA, Walensky RPJournal of urban health : bulletin of the New York Academy of MedicineImplementing a routine, voluntary HIV testing program in a Massachusetts county prison. J Urban Health. 2006 Nov; 83(6):1127-31.J Urban Health2006-11-01T00:00:002006Implementing a routine, voluntary HIV testing program in a Massachusetts county prison.17349451Campos NG, Salomon JA, Servoss JC, Nunes DP, Samet JH, Freedberg KA, Goldie SJThe American journal of medicineCost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. Am J Med. 2007 Mar; 120(3):272-9.Am J Med2007-03-01T00:00:002007Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.18077836Wolf LL, Ricketts P, Freedberg KA, Williams-Roberts H, Hirschhorn LR, Allen-Ferdinand K, Rodriguez WR, Divi N, Wong MT, Losina EJournal of acquired immune deficiency syndromes (1999)The cost-effectiveness of antiretroviral therapy for treating HIV disease in the Caribbean. J Acquir Immune Defic Syndr. 2007 Dec 01; 46(4):463-71.J Acquir Immune Defic Syndr2007-12-01T00:00:002007The cost-effectiveness of antiretroviral therapy for treating HIV disease in the Caribbean.18219077Kumarasamy N, Venkatesh KK, Mayer KH, Freedberg KThe Indian journal of medical researchFinancial burden of health services for people with HIV/AIDS in India. Indian J Med Res. 2007 Dec; 126(6):509-17.Indian J Med Res2007-12-01T00:00:002007Financial burden of health services for people with HIV/AIDS in India.20617921Walensky RP, Paltiel AD, Losina E, Morris BL, Scott CA, Rhode ER, Seage GR, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaTest and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis. 2010 Aug 15; 51(4):392-400.Clin Infect Dis2010-08-15T00:00:002010Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC.20976211Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, Deuffic-Burban S, Losina E, Freedberg KA, Danel C, Anglaret X, Yazdanpanah YPloS oneImpact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire. PLoS One. 2010 Oct 15; 5(10):e13414.PLoS One2010-10-15T00:00:002010Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire.21655097Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, Walensky RP, Mushavi A, Mugwagwa R, Dabis F, Freedberg KAPloS oneWHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PLoS One. 2011; 6(6):e20224.PLoS One2011-06-02T00:00:002011WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.14656616Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, Walensky RP, Sax PE, Freedberg KAThe American journal of medicineProjecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003 Dec 01; 115(8):632-41.Am J Med2003-12-01T00:00:002003Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.15307008Bassett IV, Freedberg KA, Walensky RPClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaTwo drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis. 2004 Aug 01; 39(3):395-401.Clin Infect Dis2004-07-16T00:00:002004Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV.15623861Walensky RP, Losina E, Malatesta L, Barton GE, O'Connor CA, Skolnik PR, Hall JM, McGuire JF, Freedberg KAAmerican journal of public healthEffective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health. 2005 Jan; 95(1):71-3.Am J Public Health2005-01-01T00:00:002005Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts.29141153Murray EJ, Robins JM, Seage GR, Lodi S, Hyle EP, Reddy KP, Freedberg KA, Hernán MAMedical decision making : an international journal of the Society for Medical Decision MakingUsing Observational Data to Calibrate Simulation Models. Med Decis Making. 2018 02; 38(2):212-224.Med Decis Making2017-11-15T00:00:002017Using Observational Data to Calibrate Simulation Models.Authorship 1027563711571094Bonds DE, Freedberg KAJournal of women's health & gender-based medicineCost-effectiveness of prenatal screening for postpartum thyroiditis. J Womens Health Gend Based Med. 2001 Sep; 10(7):649-58.J Womens Health Gend Based Med2001-09-01T00:00:002001Cost-effectiveness of prenatal screening for postpartum thyroiditis.19859538Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KAPLoS medicineCost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal. PLoS Med. 2009 Oct; 6(10):e1000173.PLoS Med2009-10-27T00:00:002009Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.20121574Robbins GK, Johnson KL, Chang Y, Jackson KE, Sax PE, Meigs JB, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPredicting virologic failure in an HIV clinic. Clin Infect Dis. 2010 Mar 01; 50(5):779-86.Clin Infect Dis2010-03-01T00:00:002010Predicting virologic failure in an HIV clinic.20209059Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, Ross D, Scott CA, Uhler LM, Katz JN, Holst H, Freedberg KAPloS oneThe "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010 Mar 04; 5(3):e9538.PLoS One2010-03-04T00:00:002010The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.12739303Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Padmanabhan L, Stein MDJournal of health care for the poor and underservedDiscontinuation from HIV medical care: squandering treatment opportunities. J Health Care Poor Underserved. 2003 May; 14(2):244-55.J Health Care Poor Underserved2003-05-01T00:00:002003Discontinuation from HIV medical care: squandering treatment opportunities.14570299Mrus JM, Yi MS, Freedberg KA, Wu AW, Zackin R, Gorski H, Tsevat JMedical decision making : an international journal of the Society for Medical Decision MakingUtilities derived from visual analog scale scores in patients with HIV/AIDS. Med Decis Making. 2003 Sep-Oct; 23(5):414-21.Med Decis Making2003-09-01T00:00:002003Utilities derived from visual analog scale scores in patients with HIV/AIDS.Authorship 10281621129161262Dunning L, Francke JA, Mallampati D, MacLean RL, Penazzato M, Hou T, Myer L, Abrams EJ, Walensky RP, Leroy V, Freedberg KA, Ciaranello APLoS medicineThe value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis. PLoS Med. 2017 Nov; 14(11):e1002446.PLoS Med2017-11-21T00:00:002017The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.20561082Hsu HE, Rydzak CE, Cotich KL, Wang B, Sax PE, Losina E, Freedberg KA, Goldie SJ, Lu Z, Walensky RPHIV medicineQuantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. HIV Med. 2011 Feb; 12(2):97-108.HIV Med2011-02-01T00:00:002011Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA.21293199Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RPAIDS (London, England)First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20; 25(4):479-92.AIDS2011-02-20T00:00:002011First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.22008655Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah YAIDS (London, England)Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. AIDS. 2012 Jan 02; 26(1):45-56.AIDS2012-01-02T00:00:002012Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.16475889Liddicoat RV, Losina E, Kang M, Freedberg KA, Walensky RPAIDS patient care and STDsRefusing HIV testing in an urgent care setting: results from the "Think HIV" program. AIDS Patient Care STDS. 2006 Feb; 20(2):84-92.AIDS Patient Care STDS2006-02-01T00:00:002006Refusing HIV testing in an urgent care setting: results from the "Think HIV" program.16878233Kimmel AD, Losina E, Freedberg KA, Goldie SJBulletin of the World Health OrganizationDiagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries. Bull World Health Organ. 2006 Jul; 84(7):581-8.Bull World Health Organ2006-07-01T00:00:002006Diagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries.7932080Freedberg KA, Malabanan A, Samet JH, Libman HJournal of acquired immune deficiency syndromesInitial assessment of patients infected with human immunodeficiency virus: the yield and cost of laboratory testing. J Acquir Immune Defic Syndr (1988). 1994 Nov; 7(11):1134-40.J Acquir Immune Defic Syndr (1988)1994-11-01T00:00:001994Initial assessment of patients infected with human immunodeficiency virus: the yield and cost of laboratory testing.23204035Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, Rusibamayila A, Keatinge J, Park JE, Maruva M, Cerda R, Wood R, Dabis F, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis. 2013 Feb; 56(3):430-46.Clin Infect Dis2012-11-30T00:00:002012Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.23318310Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BRAnnals of internal medicineEconomic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013 Jan 15; 158(2):84-92.Ann Intern Med2013-01-15T00:00:002013Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States.17668563Losina E, Yazdanpanah Y, Deuffic-Burban S, Wang B, Wolf LL, Messou E, Gabillard D, Seyler C, Freedberg KA, Anglaret XAntiviral therapyThe independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire. Antivir Ther. 2007; 12(4):543-51.Antivir Ther2007-01-01T00:00:002007The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.Authorship 103146712Authorship 1032641629200354Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BPHealth affairs (Project Hope)Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. Health Aff (Millwood). 2017 12; 36(12):2142-2150.Health Aff (Millwood)2017-12-01T00:00:002017Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.29273141Neilan AM, Dunville R, Ocfemia MCB, Salomon JA, Francke JA, Bulteel AJB, Wang LY, Hsu KK, DiNenno EA, Walensky RP, Parker RA, Freedberg KA, Ciaranello ALThe Journal of adolescent health : official publication of the Society for Adolescent MedicineThe Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV. J Adolesc Health. 2018 01; 62(1):22-28.J Adolesc Health2018-01-01T00:00:002018The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV.21388558Chu J, Sloan CE, Freedberg KA, Yazdanpanah Y, Losina EAIDS research and therapyDrug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV. AIDS Res Ther. 2011 Mar 10; 8:14.AIDS Res Ther2011-03-10T00:00:002011Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV.18422445Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KAThe Journal of infectious diseasesScaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis. 2008 May 01; 197(9):1324-32.J Infect Dis2008-05-01T00:00:002008Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.20862279Uhler LM, Kumarasamy N, Mayer KH, Saxena A, Losina E, Muniyandi M, Stoler AW, Lu Z, Walensky RP, Flanigan TP, Bender MA, Freedberg KA, Swaminathan SPloS oneCost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. PLoS One. 2010 Sep 16; 5(9).PLoS One2010-09-16T00:00:002010Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.21786730Wang B, Losina E, Stark R, Munro A, Walensky RP, Wilke M, Martin D, Lu Z, Freedberg KA, Wood RSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskundeLoss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count. S Afr Med J. 2011 Apr; 101(4):253-7.S Afr Med J2011-04-01T00:00:002011Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count.19725790Ivers LC, Cullen KA, Freedberg KA, Block S, Coates J, Webb PClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaHIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis. 2009 Oct 01; 49(7):1096-102.Clin Infect Dis2009-10-01T00:00:002009HIV/AIDS, undernutrition, and food insecurity.20482371Walensky RP, Ciaranello AL, Park JE, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaCost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. Clin Infect Dis. 2010 Jul 01; 51(1):85-92.Clin Infect Dis2010-07-01T00:00:002010Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature.22343964Lorenzana SB, Hughes MD, Grinsztejn B, Collier AC, Luz PM, Freedberg KA, Wood R, Levison JH, Mugyenyi PN, Salata R, Wallis CL, Weinstein MC, Schooley RT, Walensky RPAIDS (London, England)Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial. AIDS. 2012 Jun 01; 26(9):1083-93.AIDS2012-06-01T00:00:002012Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial.18657699Walensky RP, Freedberg KA, Weinstein MCLancet (London, England)Monitoring of antiretroviral therapy in low-resource settings. Lancet. 2008 Jul 26; 372(9635):288; author reply 289.Lancet2008-07-26T00:00:002008Monitoring of antiretroviral therapy in low-resource settings.18981776Ciaranello AL, Seage GR, Freedberg KA, Weinstein MC, Lockman S, Walensky RPAIDS (London, England)Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS. 2008 Nov 12; 22(17):2359-69.AIDS2008-11-12T00:00:002008Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.19578237Orrell C, Walensky RP, Losina E, Pitt J, Freedberg KA, Wood RAntiviral therapyHIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme. Antivir Ther. 2009; 14(4):523-31.Antivir Ther2009-01-01T00:00:002009HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme.22992315Kimmel AD, Resch SC, Anglaret X, Daniels N, Goldie SJ, Danel C, Wong AY, Freedberg KA, Weinstein MCCost effectiveness and resource allocation : C/EPatient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability. Cost Eff Resour Alloc. 2012 Sep 19; 10(1):12.Cost Eff Resour Alloc2012-09-19T00:00:002012Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.10770912Kaplan JE, Masur H, Holmes KK, Freedberg KA, Holtgrave D, Piscitelli SC, Van Dyke R, Watts HClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAn overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons. Clin Infect Dis. 2000 Apr; 30 Suppl 1:S15-28.Clin Infect Dis2000-04-01T00:00:002000An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons.23217792Orrell C, Levison J, Ciaranello A, Bekker L, Kuritzkes D, Freedberg K, Wood RJournal of the International AIDS SocietyEvolution of resistance in paediatric patients with failure on antiretroviral therapy. J Int AIDS Soc. 2012; 15(6):18086.J Int AIDS Soc2012-11-11T00:00:002012Evolution of resistance in paediatric patients with failure on antiretroviral therapy.Authorship 10084911530029Vidrih JA, Walensky RP, Sax PE, Freedberg KAThe American journal of medicinePositive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection. Am J Med. 2001 Aug 15; 111(3):192-4.Am J Med2001-08-15T00:00:002001Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection.12594648Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaReview of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis. 2003 Mar 01; 36(5):652-62.Clin Infect Dis2003-02-17T00:00:002003Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa.